The Mechanism of an Inhibitory Antibody on
TF-initiated Blood Coagulation Revealed by the
Crystal Structures of Human Tissue Factor, Fab 5G9
and TF5G9 Complex
Mingdong Huang1
, Rashid Syed1
, Enrico A. Stura1
, Martin J. Stone1
Randy S. Stefanko1
, Wolfram Ruf
2
, Thomas S. Edgington2
and Ian A. Wilson1,3
*
1
Department of Molecular
Biology, 2
Department of
Immunology and 3
Skaggs
Institute for Chemical Biology
The Scripps Research Institute
10550 N. Torrey Pines Road
La Jolla, CA 92027, USA
The tissue factor (TF)-initiated blood coagulation protease cascade can be
greatly inhibited in vivo by a potent anti-human-TF monoclonal antibody,
5G9. This antibody binds the carboxyl module of the extracellular
domain of TF with a nanomolar binding constant and inhibits the forï¿¾mation of the TFVIIaX ternary initiation complex. We have determined
the crystal structures of the extra-cellular modules of human TF, Fab
5G9, and their complex (TF5G9) to 2.4 AÃŠ , 2.5 AÃŠ , and 3.0 AÃŠ , respectively,
and measured the apparent inhibition constants of 5G9 on a panel of TF
mutants. In our unliganded TF structure, a 7 change in the relative
orientation between the D1 and D2 modules was observed when comï¿¾pared with other published TF structures. Comparison of the free and
bound Fab 5G9 indicates that small segmental and side-chain variation of
the antibody complementarity determining regions occurred on comï¿¾plexation with TF. The antibody-antigen recognition involves 18 TF antiï¿¾gen residues and 19 Fab residues from six CDRs with one of the largest
buried surface areas seen to date. A combination of structural and mutaï¿¾genesis data indicate that Tyr156, Lys169, Arg200, and Lys201 play the
major role in the antibody recognition. The TF5G9 structure provides
insights into the mechanism by which the antibody 5G9 inhibits forï¿¾mation of the TFVIIaX ternary complex.
# 1998 Academic Press Limited
Keywords: antibody-antigen interactions; blood coagulation mechanism;
*Corresponding author Fab-protein complex; X-ray crystallography; tissue factor
Introduction
Activation of the coagulation protease cascade
propels the pathophysiology of the thrombotic disï¿¾eases (reviewed by Ruf & Edgington, 1994). The
coagulation cascade is initiated by the cell surface
transmembrane receptor tissue factor (TF) which
binds serine protease factor VIIa and activates the
VIIa protease domain for full catalytic function.
The complex then proteolytically activates the
macromolecular zymogen substrates, factors IX
and X, and generates the two key intermediate
enzymes for thrombin generation and cell signalï¿¾ling. Because of its central role in initiating the
thrombogenic responses, an understanding of the
molecular mechanisms by which coagulation funcï¿¾tion can be attenuated is of wide interest and of
potential therapeutic beneÂ®t (Levi et al., 1994) in
several life-threatening diseases, including thromï¿¾bosis and disseminated intravascular coagulation
(DIC; Edgington et al., 1992).
Present addresses: R. Syed, Molecular Structure and
Design Group, Amgen Inc., 1840 DeHavilland Drive,
Thousand Oaks, CA 91320-1789, USA; M. J. Stone
Department of Chemistry, Indiana University
Bloomington, IN 47405, USA.
Abbreviations used: 5G9, an anti-TF monoclonal
antibody; CDR, complementarity determining region;
Fab, antigen binding fragment of an antibody; NCS,
non-crystallographic symmetry; MIRAS, multiple
isomorphous replacement and anomalous scattering; TF,
extracellular domain of human tissue factor that
includes D1 and D2 modules; r.m.s.d., root-mean-square
deviation; VIIa, coagulation factor VIIa.
J. Mol. Biol. (1998) 275, 873Â±894
0022Â±2836/98/050873Â±22 $25.00/0/mb971512 # 1998 Academic Press LimitedThe structure-function relationships of TF have
been advanced through systematic mutagenesis of
TF (Ruf et al., 1994; Kelley et al., 1995) and of VIIa
(Dickinson et al., 1996). These data can now be
interpreted within the context of the three-dimenï¿¾sional structures of TF (Harlos et al., 1994; Muller
et al., 1994, 1996; also reviewed by Martin et al.,
1995) and the TFVIIa binary complex (Banner
et al., 1996). The TF extracellular domain folds into
two Â®bronectin-type III modules, D1 and D2, that
are also presented in members of the cytokine
receptor family (Bazan, 1990). An extended hydroï¿¾phobic intermodule interface results in a relatively
rigid orientation of the two modules (Harlos et al.,
1994; Muller et al., 1994, 1996). The mutagenesis
experiments demonstrated that both modules conï¿¾tribute to an extended binding site for the protease
VIIa. The functionally derived ligand interface is in
excellent agreement with the interface determined
from the three-dimensional structure of the
TFVIIa complex (Banner et al., 1996). TF binds the
protease through contacts that involve each of the
various structural components of VIIa: (1) the gï¿¾carboxy glutamic acid-rich (Gla) module interacts
with a hydrophobic patch containing the solventï¿¾exposed disulÂ®de bridge of the D2 module of TF;
(2) the Â®rst epidermal growth factor-like module
(EGF-1) packs into a groove formed by the interï¿¾face between the D1 and D2 modules of TF; and
(3) EGF-2 and the protease module have a continuï¿¾ous interface with the D1 module of TF. The interï¿¾faces of VII/VIIa EGF-1 and Gla modules with TF
are formed predominantly by hydrophobic interï¿¾actions, suggesting that these two light chain modï¿¾ules provide a tether for the protease. The protease
module interacts with a cluster of residues of TF
(Banner et al., 1996) that have functional impliï¿¾cations (Dickinson et al., 1996) on the ability of TF
to confer allosteric changes to the VIIa protease
module in order to enable its full catalytic activity.
The interactions which support the assembly of
the macromolecular substrates, factors X and IX,
with TFVIIa are still not well understood. Factor
X is preferentially hydrolyzed when bound to a
phospholipid membrane, probably through its
amino-terminal Gla-module (Krishnaswamy et al.,
1992; Ruf et al., 1991c). Macromolecular substrate
activation also involves the Gla-module of VIIa
(Ruf et al., 1991a), which is oriented toward the
membrane, as deduced from the TFVIIa complex
(Banner et al., 1996). It is, therefore, reasonable to
assume that interaction of the Gla-modules of both
enzyme and substrate may play a signiÂ®cant role
in the association of TFVIIa with macromolecular
substrate to form the transient ternary complex.
Furthermore, residues Lys165 and Lys166 in the
D2 domain of TF are localized adjacent to the Glaï¿¾domain in the TF-VIIa interface, and these two
basic residues are important for activation of
macromolecular substrate (Ruf et al., 1992a).
Epitope mapping of inhibitory antibodies of TF
has also provided evidence consistent with this
model. Whereas most inhibitory antibodies are
found to compete with VIIa binding to TF, monoï¿¾clonal antibody 5G9 rapidly binds the preformed
TFVIIa and inhibits association of macromolecular
substrate (Ruf & Edgington, 1991). Antibody 5G9
displays these potent anti-thrombotic effects in vivo
and is currently being tested as a therapeutic to
interrupt TF-initiated coagulation (Edgington et al.,
1992). Antibody 5G9 is directed against the D2
module of TF (Ruf et al., 1991b) and is a competiï¿¾tive inhibitor for macromolecular substrate factor X
activation, as deÂ®ned by kinetic analysis (Ruf &
Edgington, 1991). The crystallization of TF in comï¿¾plex with a Fab fragment of this antibody (Ruf
et al., 1992b) now provides an opportunity to
investigate the structural basis of this inhibition
and of macromolecular substrate recognition by
the TFVIIa complex.
Antibody-protein complex structures have
become a paradigm for understanding protein-proï¿¾tein interactions (Jones & Thornton, 1996). The
interactions in the antibody-antigen interface are
often weaker than the corresponding subunit interï¿¾faces of multimeric proteins or of small molecule
inhibitor-protease complexes (Sheriff, 1993; Jones &
Thornton, 1996). Of the 59 antibody-antigen strucï¿¾tures that have had their coordinates deposited in
the PDB database (Bernstein et al., 1978) up to Febï¿¾ruary 1997, 20 complexes have proteins as their
antigens (for reviews, see Davies et al., 1990;
Sheriff, 1993; Wilson & StanÂ®eld, 1993, 1994;
Padlan, 1994; Webster et al., 1994; Braden & Poljak,
1995; Sheriff, 1997; Cohen et al., 1996). The antiï¿¾body-protein structures are restricted mainly to
lysozyme (Amit et al., 1986; Sheriff et al., 1987;
Padlan et al., 1989; Fischmann et al., 1991; Chitarra
et al., 1993; Bhat et al., 1994; Lescar et al., 1994;
Braden et al., 1994; Chacko et al., 1995; Cohen et al.,
1996), neuraminidase (Tulip et al., 1992a,b; Malby
et al., 1994), and anti-idiotope antibodies (Ban et al.,
1994; Fields et al., 1995; Braden et al., 1996). Other
protein antigens include histidine-containing proï¿¾tein (HPr; Prasad et al., 1993), inÂ¯uenza virus
hemagglutinin HA1 monomer (Bizebard et al.,
1995), and N10-staphylococcal nuclease (Bossartï¿¾Whitaker et al., 1995).
Extensive conformational changes in an antibody
upon binding small molecular mass antigens have
been illustrated, for example, in anti-peptide Fab
17/9 (Rini et al., 1992), anti-DNA Fab BV04
(Herron et al., 1991) and anti-HIV-1 Fab 50.1
(StanÂ®eld et al., 1993). These structures provided
clear evidence for induced Â®t as a mechanism for
antibody-antigen recognition (Rini et al., 1992;
StanÂ®eld et al., 1993). It now appears that there is a
wide range of variation in the extent of conforï¿¾mational changes induced by a ligand in different
antibody systems. For protein antigens, the antiï¿¾gen-induced antibody conformational changes
have so far been of lesser magnitude than those
seen with some hapten or peptide ligands. In this
study, the crystal structures of TF and Fab 5G9
have been determined in both free and liganded
forms. Evaluation of any antibody conformational
874 Crystal Structures of TF, 5G9 Fab and Their Complexchanges following antigen binding can then be
made, as well as assessment of the relative contriï¿¾butions of polar and hydrophobic interactions to
the stability of the antibody-antigen complex.
Results and Discussion
Crystal structure of Fab 5G9
The current Fab 5G9 (isotype IgG1, k) model
consists of residues 1 to 214 from both the light
chain and the heavy chain. The Fab 5G9 structure
was reÂ®ned to an R-value of 21.1% and an Rfree
value (BruÃˆ nger, 1992a) of 30.4% for data between
8 AÃŠ and 2.5 AÃŠ (Table 1). The 5G9 model has an
excellent overall Â®t to 2Fo Ã¿ Fc maps with an averï¿¾age real space correlation coefÂ®cient (Jones et al.,
1991) of 0.87 for main-chain atoms. Residues that
have relatively low real space correlation coefÂ®-
cients are all in solvent-exposed regions with highï¿¾er-than-average thermal parameters. Most of the
residues are clustered in energetically favorable
(89.3%) or allowed (98.1%) regions of the Ramaï¿¾chandran plot. AlaL51 of the light chain is located
as usual in a less favorable region that corresponds
to position (i Â‡ 1) of a classic g turn (Milner-White
et al., 1988), as found in other Fab structures
(StanÂ®eld et al., 1990; Rini et al., 1992; Tulip et al.,
1992a; Arevalo et al., 1993; Braden et al., 1994;
Malby et al., 1994).
Fab 5G9 is like a typical anti-protein antibody
with a concave and undulating surface (Wilson &
StanÂ®eld, 1994). The elbow angle in Fab 5G9 is
133.0. The conformations of CDR loops L1, L2, L3,
H1, and H2 are consistent with their sequence-preï¿¾dicted canonical structure types (Chothia et al.,
1989), which are type 2, 1, 1, 1, and 2, respectively.
Crystal structure of tissue factor
The TF crystal has two molecules (I and II) in
the crystal asymmetric unit. The current TF model
contains residues 5 to 83, and 89 to 211 for molï¿¾ecule I, and residues 5 to 83, 89 to 115, 121 to 134,
138 to 157, 164 to 182 and 186 to 210 for molecule
II. The missing TF residues include the N-terminal
residues (1 to 4) for molecule I, a loop in the D1
module of TFs that connects strands F and G (resiï¿¾dues 84 to 88), which is also poorly deÂ®ned in
other TF structures (Harlos et al., 1994; Muller et al.,
1994, 1996), and some shorter loops (116 to 120,
135 to 136, 158 to 163, 183 to 185) in the membrane
proximal D2 module of molecule II. The two TF
molecules have been reÂ®ned to an R-value of
21.7% and an Rfree value of 29.7% between 8 and
2.4 AÃŠ . Most of the residues (86.1%) have energetiï¿¾cally favorable conformations and no residues
have disallowed conformations.
The two TF molecules in the asymmetric unit are
related by a 90.5 rotation about the crystalloï¿¾graphic axes [0.0, 0.95, Ã¿0.30] and a translation of
101.9 AÃŠ , Ã¿0.7 AÃŠ , Ã¿12.5 AÃŠ , which corresponds to a
very small peak (1s) in the self-rotation function.
The r.m.s.d. between the two TF molecules for 177
Ca atoms is 0.38 AÃŠ . Ramachandran plots of the two
TF molecules are similar with r.m.s. differences on
phi and psi of 9.7 and 10.7, respectively (as calcuï¿¾lated by LSQMAN; Kleywegt & Jones, 1994a). The
Table 1. Data collection and crystallographic reÂ®nement statistics for tissue factor, Fab 5G9 and the TF5G9 complex
Tissue factor (TF) Fab 5G9 TF5G9 complex
Space group P212121 P212121 P2
Cell dimensions (AÃŠ ) a Âˆ 64.4, b Âˆ 85.8, c Âˆ 112.9 a Âˆ 91.6, b Âˆ 93.7, c Âˆ 60.7 a Âˆ 142.3, b Âˆ 73.3, c Âˆ 116.0, b Âˆ 90.9
No. mol/asym. unit 2 1 2
No. of crystals 1 1 4
Percent solvent (%) 55 46 64
No. of observations 64,590 86,379 118,598
No. of unique refs 26,432 19,394 42,650
Data resolution (AÃŠ ) 2.27 (2.37)
a 2.39 (2.54) 3.0 (3.18)
Data completeness (%) 90.0 (52.6)
a 90.5 (58.5) 90.8 (87.0)
Average I/s(I) 21.0 (1.5)a 19.8 (2.4) 7.2 (0.9)
Rsym on intensityb 7.3 (43.6)
a 7.5 (18.2) 13.5 (44.6)
R-valuec (%)/No. refs 21.7/20,860 21.1/16,666 20.6/34,656
R-freec
(%)/No. refs 29.7/2038 30.4/2038 27.6/889
Resolution (AÃŠ ) 8Â± 2.4 8Â±2.5 7.0Â± 3.0
Protein atoms 3089 3305 9834
No. of water molecules 14 0 0
r.m.s.d. bond lengths,
Bond angles (AÃŠ ), () 0.012, 1.9 0.015, 2.0 0.013, 2.2
r.m.s.d. of NCS atoms (AÃŠ ) 0.38 for 177 Ca atoms N/A 0.24 for all Ca atoms
Coord. errorsd (AÃŠ ) 0.34 (0.43) 0.27e 0.35 (0.52)
a Numbers in parentheses are statistics for data in the outer shell.
b Rsym Âˆ |I(h)i Ã¿ hI(h)i|/I(h)i
, with I(h)i
, observed intensity in the ith data set and hI(h)i, mean intensity of reÂ¯ection h over
all measurements of I(h). c R Âˆ |Fo Ã¿ Fc|/Fo, see BruÃˆnger, 1992a for Rfree deÂ®nition. d Coordinate errors were estimated from Luzzati plots (Luzzati, 1952) using a low resolution cutoff of 5 AÃŠ ; the numbers in parï¿¾entheses are estimated from cross-validated Luzzati plots. e Rfree was calculated after structural reÂ®nement was Â®nished. Cross-validated Luzzati error was not estimated.
Crystal Structures of TF, 5G9 Fab and Their Complex 875pattern of B-values of the two TF molecules is simiï¿¾lar with a correlation coefÂ®cient of 0.71. However,
molecule I has a lower overall B-value (40 AÃŠ 2
) than
molecule II (62 AÃŠ 2
) due to more contacts with symï¿¾metry-related molecules (>140 for distances less
than 5.0 AÃŠ ) than for molecule II (ten contacts). Molï¿¾ecule I is thus used in the subsequent analyses.
Crystal structure of TF5G9 complex
The TF5G9 molecule is ``L'' shaped with
molecular dimensions of 77 AÃŠ  78 AÃŠ  101 AÃŠ
(Figure 1). The TF5G9 complex crystals contain
two molecules in the asymmetric unit of the crysï¿¾tal. Each of the two TF5G9 models consists of resiï¿¾dues 1 to 214 for both Fab light and heavy chains
and residues 4 to 82, and 91 to 211 for TF. As in
the unliganded TF structure, some residues (83 to
90) in TF D1 module could not be located in the
electron density maps and were omitted from the
Â®nal model. The current model has an R-value of
20.6% and an Rfree value of 27.6% for reÂ¯ections
between 7.0 AÃŠ and 3.0 AÃŠ (Table 1).
The two molecules in the crystal are related by a
75 rotation around the crystallographic b-axis
with a translation component of 71.4 AÃŠ , 59.6 AÃŠ ,
57.2 AÃŠ , which corresponds to the strongest nonï¿¾crystallographic peak (9s) in the self-rotation funcï¿¾Figure 1. Two orthogonal views of the TF5G9 complex in stereo. TF is in magenta; Fab 5G9 heavy and light chains
are in blue and light blue. A loop in TF (residues 83 to 90) was not seen in the electron density and is represented by
a broken line. N and C represent the amino and carboxyl termini, respectively. Figures 1 to 6, 8 and 9 were created
by MidasPlus2.0 (Ferrin et al., 1988; Huang et al., 1991).
876 Crystal Structures of TF, 5G9 Fab and Their Complex  tion map. The r.m.s. deviations between the two
complexes are 0.24 AÃŠ for all Ca atoms and the
r.m.s. differences of main-chain torsional angles
phi and psi are 9.1 and 8.9, respectively, which
illustrates that the two complexes are highly simiï¿¾lar. However, the average B-value of the second
complex B (42 AÃŠ 2
) is slightly higher than that of
the Â®rst complex A (33 AÃŠ 2
) and corresponds to a
lower real space correlation coefÂ®cient (0.77 versus
0.81). Hence, molecule A is used in the following
analyses unless otherwise stated.
Fewer residues (74%) are clustered in the most
favorable region of the Ramachandran plot comï¿¾pared to the unliganded TF and 5G9 as expected
from the lower resolution (3 AÃŠ versus 2.4 to 2.5 AÃŠ ).
All residues are within allowed regions except for
AlaL51 and SerH97 in both molecules. As in the
uncomplexed 5G9 antibody, AlaL51 is in a classic
g turn (Milner-White et al., 1988). In the unliganded
5G9 antibody, SerH97 of CDR H3 is in the (i Â‡ 1)
position of a type IV loop, as identiÂ®ed by proï¿¾gram NAOMI (Brocklehurst & Perham, 1993), in
which it has an allowed left-handed helix conforï¿¾mation with phi, psi values of 92.0 and Ã¿27.1,
respectively. In the TF5G9 complex, the mainï¿¾chain carbonyl oxygen of SerH97 binds to TF
Lys169 Nz through a hydrogen bond, which results
in a less favorable conformation for SerH97 (phi,
psi angles of 96.3 and Ã¿50.0, respectively).
TF5G9 is the second reported protein structure
that crystallizes in space group P2 as found from a
survey of the February 1997 release of the PDB
database (Bernstein et al., 1978). The only other
macromolecule entry in a P2 space group is for
pyruvate phosphate dikinase (PDB code 1dik,
Herzberg et al., 1996). As pointed out by Wukovitz
& Yeates (1995) in their discussion of the crystal
packing of monomeric proteins, P2 is an unfavored
space group for protein crystals. The TF5G9
crystal has some very large solvent channels with
cross sections of 22 AÃŠ  56 AÃŠ , 22 AÃŠ  22 AÃŠ , and
26 AÃŠ  31 AÃŠ along the crystallographic a, b and
c-axes, respectively (Figure 2). The intermolecular
packing interactions are dominated by b-strand Â±bï¿¾strand interactions between two neighboring molï¿¾ecules. This unusual packing and peculiar L-shape
of the complex (Figure 1) might account for the
adoption of a P2 lattice, and explain the fragility
and the weak diffraction of the crystals (I/sI of 7.2
to 3 AÃŠ ).
D1 and D2 module association in TF structures
Two human TF structures have been previously
determined at 2.2 AÃŠ (Harlos et al., 1994, PDB code
1boy) and at 2.4 AÃŠ (Muller et al., 1994, PDB code
1hft), followed by a 1.7 AÃŠ structure (Muller et al.,
1996, PDB code 2hft). Both human TFs crystallized
in the same space group, P41212, with the same cell
parameters and one molecule in the asymmetric
unit. The two structures are highly similar with a
r.m.s.d of 0.44 AÃŠ for 194 Ca atoms. The overall
structure of TF in the TFVIIa complex is also very
similar to that of the uncomplexed TFs with a
r.m.s.d. of 0.53 AÃŠ for 170 Ca atoms (Banner et al.,
1996). The only signiÂ®cant difference was a small
shift in the loop containing Leu133 and Phe144.
The TF in our TF5G9 complex structure is simiï¿¾lar to the published TFs with an r.m.s.d. of 0.61 AÃŠ
for 185 Ca atoms (compared to 2hft). Our unliï¿¾ganded TF differs from these TF structures with an
overall r.m.s. deviation of 1.33 AÃŠ for 197 correï¿¾sponding Ca atoms (compared to 2hft). Superposiï¿¾tion of the individual D1 and D2 modules,
however, shows much lower r.m.s.d. values of
0.59 AÃŠ for 89 D1 Ca atoms and 0.57 AÃŠ for 98 D2 Ca
atoms. Calculation of the intermodule angle
between D1 and D2 modules by program O (Jones
et al., 1991) shows that our unliganded TF structure
has an intermodule angle of 134 for both TF molï¿¾ecules I and II, different from those of 2hft (127)
and 1boy (127). So, despite a large intermodule
hydrophobic interaction (Muller et al., 1996), a limï¿¾ited degree of orientational Â¯exibility (7)
between the TF D1 and D2 modules is permitted
(Figure 3). Compared with the other TF structures
Figure 2. Stereoview of the crystal cell packing of TF5G9 complex in a rare space group, P2, for macromolecules
along the crystallographic b-axis. A big solvent channel can be seen with a cross section of 22 AÃŠ  56 AÃŠ . The two TF
models are shown in red and the non-crystallographically related Fab 5G9s are shown in green and cyan.
Crystal Structures of TF, 5G9 Fab and Their Complex 877    which were expressed either as secreted or soluble
cytosolic proteins in Escherichia coli, our unliganded
TF molecule was a refolded protein from the
inclusion bodies in E. coli. Also our TF was crystalï¿¾lized in a low-salt medium compared to the other
TFs (see Materials and Methods). It is not clear
Figure 3. Comparison of our free TF structure compared to the 2hft (PDB code) structure in stereo shows a 7 differï¿¾ence in the angle relating the D1 and D2 modules. The free TF (molecule I) from this study is shown in magenta;
shown in blue is 2hft. Both TF structures were aligned through their D2 modules. The D1 module is on top and the
D2 module below.
Figure 4. Comparison of CDR loops and some selected side-chains in stereoview between free (green) and TF-bound
5G9 Fab (magenta). Some minor, but signiÂ®cant, movements occur in some of the CDR residues. The largest Ca atom
shifts (more than 1 AÃŠ ) are seen for Arg30L(L1), Gly92L(L3), Glu93L(L3), and Ser97H(H3). The free and bound Fab
5G9s were superimposed by aligning their framework residues. The light and heavy chain CDR loops are labeled L1
to L3 and H1 to H3.
878 Crystal Structures of TF, 5G9 Fab and Their ComplexTable 2. The TF5G9 complex has one of the largest antibody-protein interfaces. Comparison of the TF5G9 complex with other antibody-protein complexes in terms of VLï¿¾V
H rotation angle, VL-V
H buried surface area, number of residues in CDR-H3 loop, and antibody-antigen buried surface areas
VL-VH Contact area of Fab-antigen interface
PDB Rot Area Fab Ag VL VH L-CDR (%) H-CDR (%)
codea Fab Antigen (
) ÃŠ (A2
) H3a (AÃŠ 2) (AÃŠ 2) (%) (%) 1 2 3 1 2 3 References
1a
hw 5G9 TF 2.8 1439 8 923 891 32.6 67.4 10 4 17 20 26 19 This work
1iai 409.5.3 730.1.4 1693 8 869 890 28.0 72.0 4 0 21 15 29 10 Ba
n et al., 1994
1ncc N
C41 I368
R
N9 1321 11 981 869 46.9 53.1 3 23 15 11 11 29 Tulip et al., 1992a,b
1nca N
C41 Tern
N9 1271 11 869 840 45.1 54.9 1 22 17 11 13 28 Tulip et al., 1992a,b
1ncd N
C41 Whale N9 1259 11 902 853 46.8 53.2 1 23 17 11 13 27 Tulip et al., 1992a,b
1ncb N
C41 N329
D
N9 1268 11 875 823 46.3 53.7 2 23 16 11 12 29 Tulip et al., 1992a,b
1ns
n N10 Staphylococcal nuclease 1120 4 793 827 48.5 51.5 20 6 19 9 32 6 Bossartï¿¾Whitaker et al., 1995
1dvf E5.2-Fv D1.3-Fv 1750 13 708 726 20.6 79.4 4 5 11 7 17 54 Brade
n et al., 1996
1jel Jel42 Hpr 1569 9 617 651 32.0 68.0 26 0 6 12 27 28 Prasad et al., 1993
1nmb N
C10-Fv Whale N9 1353 13 646 627 48.7 51.3 19 2 27 0 28 23 Malby et al., 1994
1fbi F9.13.7 GEL 1750 13 772 751 26.9 73.1 4 0 23 18 32 23 Lescar et al., 1994
3hfl HyHEL5 HEL 1329 7 720 774 43.0 57.0 12 12 17 18 25 9 Co
hen et al., 1996
1bql HyHEL5 BEL 1346 7 756 726 43.8 56.2 15 2 25 14 26 13 C
hacko et al., 1995
3hfm HyHEL10 HEL 1411 5 720 774 43.0 57.0 12 12 17 18 25 9 Padlan et al., 1989
1vfb D1.3-fV HEL 2.2 1467 8 596 617 44.6 55.4 12 12 17 11 16 27 Bhat et al., 1994
1mlc D44.1 HEL 2.6 1250 7 633 616 35.0 65.0 5 5 26 26 27 9 Brade
n et al., 1994
2iff HyHEL5 R68
K HEL 1350 7 627 564 48.8 51.2 13 1 31 10 24 14 C
hacko et al., 1995
1fdl D1.3 HEL 2.8 1453 8 556 538 43.2 56.8 9 14 17 10 19 26 Fischman
n et al., 1991
1j
hl D11.15 PEL 1398 9 614 562 35.0 65.0 7 3 23 18 22 24 C
hitarra et al., 1993
a Only Fab-protein complexes with full coordinates deposited in the PDB are listed here. The VL-VH rotatio
n angle upon binding (StanÂ®eld et al., 1993) was calculated for Fabs where full coordiï¿¾nates of both the free (unliganded) and antigen-bound structures are available. VL and VH, variable domain of heavy and light chain of Fab: Ag, antigen; HEL, hen egg lysozyme; PEL, pheasant
egg lysozyme; BEL, bobwhite quail egg white lysozyme; GEL, guineafowl egg white lysozyme; N9, N9 neuraminidase; HPr, histidine-containing phosphocarrier protein.what relationship these factors have to the differï¿¾ence in the intermodule angles.
Conformational changes in Fab 5G9 upon TF
antigen binding
The elbow angle of Fab 5G9 in the TF5G9 comï¿¾plex (129) is close to that of the unliganded Fab
(133) at the lower end of those observed in Fab
structures (127 to 227, Wilson & StanÂ®eld, 1994).
A comparison of all 428 Ca atoms between free
and bound Fab 5G9 gives an r.m.s.d. of 0.72 AÃŠ .
The corresponding r.m.s. difference for the Ca
atoms of the CDR loops is 0.64 AÃŠ , comparable to
the overall r.m.s. difference for all Ca atoms and,
thus, indicates that the overall structure, as well as
the combining site, of the free and bound Fab 5G9
is similar (Figure 4). The largest Ca atom shifts in
the CDR loops upon complex formation are in
CDR L3 residues GlyL92 (1.5 AÃŠ ) and AsnL93
(1.8 AÃŠ ).
Despite these small overall shifts in the CDR
loops, some differences appear signiÂ®cant
(Figure 4). The light chain CDRs have slightly larï¿¾ger Ca r.m.s. deviations (0.79 AÃŠ ) than those of the
heavy chain (0.52 AÃŠ ). The individual CDRs have
r.m.s. deviations of 0.80 AÃŠ , 0.65 AÃŠ , 0.87 AÃŠ , 0.16 AÃŠ ,
0.47 AÃŠ , and 0.75 AÃŠ for L1, L2, L3, H1, H2, and H3,
respectively. The shifts of L1 and L3 loops are
small, but larger than the overall r.m.s.d. values of
the 5G9 light chain. In addition, a 30 swing of the
TyrH98 side-chain is critical for making two hydroï¿¾gen bonds to the TF main-chain carbonyl oxygen
of Lys149 and the side-chain amide group of
Asn171 (Figure 5).
StanÂ®eld et al. (1993) have observed a substantial
rotation (16) of the variable heavy (VH) chain relaï¿¾tive to the variable light (VL) chain in Fab 50.1-pepï¿¾tide complex. They also proposed that this VLÂ±VH
rotation is related to the length of CDR H3 loop
and the size of the buried surface area at the
VLÂ±VH interface. The availability of both free and
TF-bound 5G9 allows us to calculate the Fab 5G9
VLÂ±VH rotation angle upon antigen binding. Fab
5G9 has a relatively large VLÂ±VH interface
(1439 AÃŠ 2
) compared with the smallest observed so
far for Fab 50.1 (1063 AÃŠ 2
; StanÂ®eld et al., 1993;
Table 2). Upon TF antigen binding, Fab 5G9 underï¿¾goes only a small VLÂ±VH rotation (2.8), that is
similar to that seen in other Fab-protein complexes
(Table 2).
Antibody-antigen interactions
The six CDRs of Fab 5G9 form a large and someï¿¾what concave surface. The tips of the CDRs are all
approximately in the same plane with a small
depression between VL and VH particularly on the
VH side (Figure 1). From these CDRs, 19 residues
interact with 18 antigen residues from four of the
six b strands (C0
, C, F and G) of TFs D2 module
(Figure 6). The TF epitope consists of
C-strand residues Lys149, Ile152, Thr154, Tyr156,
C0
-strand residues Lys165, Lys166, Thr167, Ala168,
Lys169, Thr170, Asn171, F-strand residues Gln190,
Val192, Pro194, and G-strand residues Val198,
Arg200, Lys201, Asp204 (Table 3).
The interacting surfaces of TF and Fab 5G9
(Figure 7) have a good shape and charge compleï¿¾mentarity, a feature observed in other antibodyï¿¾protein antigen systems and a recurrent feature of
antibody-antigen recognition (Davies et al., 1990;
Wilson et al., 1991a,b; Wilson & StanÂ®eld, 1993,
1994; Padlan, 1994; Webster et al., 1994; Davies &
Cohen, 1996). The surface areas buried on TF and
Fab 5G9 as a result of the complex formation are
891 AÃŠ 2 and 923 AÃŠ 2 (Table 2), respectively, as calcuï¿¾lated by program MS with a 1.7 AÃŠ probe
(Connolly, 1983), which is one of the largest antiï¿¾body-antigen interaction surfaces seen so far
(observed range for protein antigens and Fabs are
538 to 901 AÃŠ 2 and 556 to 982 AÃŠ 2
, respectively, see
Table 2).
The framework residues of the antibody usually
contribute only a very small surface area to antigen
binding (Wilson & StanÂ®eld, 1994), as seen here
Figure 5. Interaction of TF C0
-strand with Fab 5G9. Residue Lys169 of TF C0
-strand (magenta) is accommodated in a
pocket between the Fab CDRs L3 and H3 (magenta). The unliganded Fab 5G9 L3 and H3 CDR loops are shown in
green and were superimposed on the liganded structure through the framework residues. The subtle movement of
5G9 H3 and L3 loops in the bound form allows formation of six hydrogen bonds with TF.
880 Crystal Structures of TF, 5G9 Fab and Their Complexwith only 5% of the total contact area (Table 2).
The heavy chain accounts for 67% of the total antiï¿¾body-antigen contact surface, whereas the light
chain only contributes 33%. This skewed percenï¿¾tage of contact area for the light chain is at the
lower end of the observed range for known antiï¿¾body-protein complexes (ranging from 21% for Fv
E5.2 to 49% for Fab HyHEL-5, Table 2), and closer
to those seen in antibody-peptide or antibody-hapï¿¾ten complexes (10% to 40%; Wilson & StanÂ®eld,
1994). The light chain makes 32 contacts (eight, six,
and 18 for L1, L2, and L3, respectively) to the antiï¿¾gen, whereas the heavy chain contributes 109 of
the total 141 contacts (47, 39, 23 for H1, H2, and
H3, respectively). A total of 15 hydrogen bonds
(ten VH, Â®ve VL) occurs between TF and 5G9 with
two main-chain Â±main-chain hydrogen bonds from
Thr167 O Â±SerL94 N (L3) and Lys169 N Â±GlyL92 O
Figure 6. Interactions in the TF5G9 interface. Top stereoview shows the overall orientation and the interaction
between some b-strands (labeled in green) of the D2 module of TF (green) with the CDRs of Fab 5G9 (blue and pale
blue for heavy and light chains); bottom stereoview shows all 15 hydrogen bonds (Table 5) and all residues (labeled
in black for Fab 5G9 and green for TF) involved in the TF5G9 interaction (Table 3).
Crystal Structures of TF, 5G9 Fab and Their Complex 881Table 3. Interactions between TF and Fab 5G9
Lys Ile Thr Tyr Lys Lys Thr Ala Lys Thr Asn Gln Val Pro Val Arg Lys Asp
Fab CDR TF: 149 152 154 156 165 166 167 168 169 170 171 190 192 194 198 200 201 204 Total
L1 L30 Arg    1a          1
L32 Tyr          3 4        7
L2 L50 Tyr 2    4     6
L3 L92 Gly    3 2a          5
L93 Glu    3       3
L94 Ser    1 7b            8
L96 Tyr         2          2
H1 H30 Lys      3a  3
H31 Asp               7 5a 5  17
H32 Tyr            13 2  15
H33 Tyr   4b 2     5a 1      12
H2 H52 Asp    5a     5   2a  12
H53 Glu                 2  2
H54 Asn                  9 9
H56 Asn    3 9              12
H58 Ile    2   2       4
H3 H96 Asn      3  4a   7
H97 Ser    1a    1      2
H98 Tyr 6a 4    1a   3     14
Total: 8 4 4 12 9 1 12 3 6 3 9 10 2 6 7 22 14 9 141
The numbers listed here include hydrogen bonds, salt bridges and van der Waals interactions (less than 3.9 AÃŠ between the epitope
residues of TF and Fab 5G9's CDR residues, in Kabat and Wu numbering: Kabat et al., 1991). a Indicates one hydrogen bond is made.
b Indicates two hydrogen bonds are made. The Table was calculated by HBPLUS (McDonald & Thornton, 1994).
Figure 7. An ``open-book'' (along the yellow line) represention of the contact surfaces of the TF5G9 complex shows
the charge and shape complementarity between Fab 5G9 (right) and antigen TF (left). The surface was color-coded
from blue to red for positive and negative charge. The interacting surface of the TF D2 module is positively charged
(K166, K169, R200, K201), whereas the antibody generally has complementary negatively charged residues (D95H,
E93L, D52H). The charge distribution was calculated by GRASP (Nicholls et al., 1991).
882 Crystal Structures of TF, 5G9 Fab and Their Complex(L3) (Tables 3 and 5), which is typical (six to 17,
Davies & Cohen, 1996) for antibody-protein comï¿¾plexes.
The TF epitope residues can be grouped into
four linear polypeptide segments (Table 3 and
Figure 6). The C-strand residues 149 to 156 only
interact with 5G9 VH and account for approxiï¿¾mately 20% of the total van der Waals contacts (28)
and buried surface area (165 AÃŠ 2
). On the other
hand, residues 165 to 171 of the C0
-strand segment
interact primarily with 5G9 VL, with seven hydroï¿¾gen bonds, four of which involve TF main-chain
atoms. Indeed, the CDR L3 loop resembles a short
antiparallel b-strand interacting with the TF C0
-
strand and extending the C0
, C, F, G b-sheet of TF
(Figure 6). This TF segment accounts for 30 to 39%
of all interactions in terms of van der Waals conï¿¾tacts (43) and buried surface area (330 AÃŠ 2
). Resiï¿¾dues 200 to 204 of strand G contribute 22 to 32% of
total interactions (45) and buried surface area
(201 AÃŠ 2
). Strand F has fewer interactions (17% of
total) for residues 190 to 198 (25 van der Waals
contacts and 153 AÃŠ 2 of buried surface) with Fab
5G9.
Although many TF residues are involved in the
TF5G9 interactions, a few key residues (Novotny
et al., 1989) can be identiÂ®ed based on the current
TF5G9 structure. Tyr156 of the TF C-strand makes
12 contacts with the heavy chain of Fab 5G9,
which include one hydrogen bond between its
side-chain OH and AspH52 Od
2 of CDR H2
(Tables 3 and 5). This residue uses one third of its
side-chain surface (60.0 AÃŠ 2 out of total 187 AÃŠ 2
;
Table 4; Miller et al., 1987) to interact with Fab
5G9. Another key TF epitope residue is Lys169 in
the C0
-strand, which is deeply buried in a pocket
formed by CDR loops L1, L3 and H3. The contact
area between Lys169 and 5G9 is 101 AÃŠ 2 (78 AÃŠ 2
from the side-chain), which is almost one-half of
the total surface area of a lysine residue (211 AÃŠ 2
;
Table 4. Correlation of mutational analysis with TF5G9 structural data
VDW Buried surface (AÃŠ 2
) G
Residue contacts Main Side Total TF Mutants Ki (M) (kcal/mol)
122 K 0 0.0 7.0 7.0 T121A, K122A 1.0(0.9)  10Ã¿8 0.6
149 K 8 7.8 23.8 31.7 K149A, D150A 2.5(0.4)  10Ã¿8 1.2
150 D 0 3.6 2.1 5.8
152 I 4 0.0 37.0 37.0 I152Q, T154I, Y156T >2.8  10Ã¿6 >4.0
154 T 4 0.0 17.7 17.7
156 Y 12 0.0 60.0 60.0 Y156A >2.1  10Ã¿6 >4.0
157 Y 0 0.0 11.8 11.8 Y157A 1.4(0.6)  10Ã¿10 Ã¿1.9
158 W 0 0.0 1.1 1.1
164 G 0 10.3 0.0 10.3
165 K 9 19.5 32.8 52.3 K165A, K166A 3.6(2.0)  10Ã¿10 Ã¿1.3
166 K 1 8.1 26.0 34.1
167 T 12 25.0 34.6 59.6 T167A 3(2.4)  10Ã¿9 0.0
168 A 3 7.7 15.0 22.7
169 K 6 22.9 78.1 101.0 K169A, N171A, N173A >3.0  10Ã¿6 >4.0
170 T 3 12.1 9.5 21.6 T170A 2.2(0.7)  10Ã¿8 1.0
171 N 9 0.0 28.7 28.7
174 E 0 1.8 0.0 1.8
175 F 0 4.9 5.1 10.0
176 L 0 5.6 2.0 7.6 L176A 1.8(0.71)  10Ã¿8 1.0
177 I 0 4.5 5.1 9.6
178 D 0 1.7 10.1 11.8 D178A 1.5  10Ã¿9 Ã¿0.5
188 S 0 0.0 5.5 5.5
190 Q 10 0.0 26.4 26.4
192 V 2 0.0 22.2 22.2
194 P 6 4.0 30.5 34.6
196 R 0 5.1 0.0 5.1 S195A, R196A >3.0  10Ã¿6 >4.0
197 T 0 17.8 12.4 30.2 T197A 3.3(1.5)  10Ã¿8 1.3
198 V 7 17.5 7.3 24.8 V198A 2.0(0.87)  10Ã¿9 Ã¿0.3
199 N 0 3.2 0.4 3.7 N199A 2.1(1.2)  10Ã¿8 1.1
200 R 22 1.5 63.1 64.7 R200A, K201A >3.0  10Ã¿6 >4.0
201 K 14 10.0 65.4 75.4
202 S 0 11.4 0.0 11.4
203 T 0 4.4 7.8 12.2
204 D 9 0.0 37.3 37.3
Total 210.4 685.5 896.7 AÃŠ 2
The number of van der Waals contacts for each TF residue is taken from Table 3. The contact surface areas (AÃŠ 2
) for
side-chain and main-chain atoms of TF epitope residues are calculated by the program MS (Connolly, 1983) with a
1.7 AÃŠ probe radius (Gelin & Karplus, 1979). The total contact surface areas are zero for other TF residues not listed
here. The right side of the Table shows the Ki values for the inhibition of the mutant TFVIIa complex by 5G9. The Ki
for inhibition of wild-type TFVIIa complex on factor X activation by Fab 5G9 is 3.4(0.3)  10Ã¿9 M; corresponding to
a G of Ã¿11.5 kcal/mol. G is the difference between G values of TF mutants and wild-type TF
(Gmutant Ã¿ Gwild-type). The standard errors shown are from three independent measurements. The number of van der
Waals contacts were taken from Table 3.
Crystal Structures of TF, 5G9 Fab and Their Complex 883                 Miller et al., 1987). This interaction involves six van
der Waals contacts and three main-chain and sideï¿¾chain hydrogen bonds (Figures 5 and 6; Table 5).
Two basic TF residues, Arg200 and Lys201, also
appear to play a key role in antibody binding.
These two residues alone contribute 140 AÃŠ 2 (mostly
from their side-chains, Table 4) of the total 891 AÃŠ 2
antigen contact surface area, and make 36 out of
the total 141 antibody-antigen contacts (Table 3).
Their side-chains form four hydrogen bonds with
the 5G9 heavy chain (Figure 6), three of which are
with 5G9 main-chain atoms and one with an acidic
side-chain, AspH52, from CDR H2 which becomes
completely buried in the interface. Hydrogen
bonds between charged groups have been proï¿¾posed (Fersht et al., 1985) to be stronger (4.5 kcal/
mol) than regular hydrogen bonds (two to three
kcal/mol). In a study of the HyHEL-5-HEL comï¿¾plex (Chacko et al., 1995), a 1000-fold reduction in
the binding constant of a lysozyme mutant (R68K)
was ascribed mainly to the loss of only one antiï¿¾body-antigen charged hydrogen bond. Thus, the
large contact area and the polar hydrogen bonds
between TF Arg200 and Lys201 and Fab 5G9, plus
a good charge complementarity (Figure 7), implies
that Arg200 and Lys201 are critical residues for
antibody 5G9 recognition.
All these key residues (Tyr156, Lys169, Arg200,
and Lys201) are quite polar. In fact, the whole TFï¿¾5G9 interface is polar and hydrophilic in nature
(Table 3), in contrast to typical mutimeric proteins,
which usually have hydrophobic interfaces (Jones
& Thornton, 1996).
Water molecules have now been recognized as
playing an important role in the antibody-antigen
interface (Bhat et al., 1994; Wilson & StanÂ®eld,
1994; Cohen et al., 1996). The TF5G9 model does
not include any water molecules due to the moderï¿¾ate resolution of the structure determination. Only
three small cavities are found in the antibody-antiï¿¾gen interface that are primarily apolar and hydroï¿¾phobic. The largest cavity lies between TF Thr154
and the CDR H1 and H2 loops with a volume of
36 AÃŠ 3
. Although this cavity analysis is based on
the 3 AÃŠ complex structure, it seems to disfavor a
major role for water molecules in this antibodyï¿¾antigen interface. However, no conclusive asserï¿¾tions can be made until a higher resolution strucï¿¾ture of the complex is obtained.
Comparison of mutagenesis data with the
TF5G9 structure
In many cases, protein-protein interactions are
dominated by only a few ``hot spot'' residues
(Novotny et al., 1989; Covell & Wallqvist, 1997).
Some examples are human growth factor Â±human
growth factor receptor complex (Clackson & Wells,
1995; Wells, 1996), NC41 FabÂ±N9 inÂ¯uenza virus
neuraminidase (Nuss et al., 1993), and barnase-barï¿¾star (Schreiber & Fersht, 1993). An analysis of the
barnase-barstar interface (Schreiber & Fersht, 1995)
by single mutations and double mutant cycles
(Carter et al., 1984; for a recent review, see
Horovitz, 1996) has identiÂ®ed two strong interï¿¾actions (with coupling energies of more than
3.0 kcal/mol) that had not been noted previously
from examination of the crystal structure as the
interacting distances were greater than 4.4 AÃŠ . The
authors conclude that an interaction cannot simply
be assessed by distance alone. On the other hand,
a recent calculation of protein-protein binding free
energy (Covell & Wallqvist, 1997), based on
changes in buried surface area due to residue-resiï¿¾due contacts and nearby crystallographic water
molecules (Wallqvist & Covell, 1996) has found
that all the interactions identiÂ®ed by double
mutant cycles in the barnase-barstar system can be
fully accounted for by considering water molecules
in the barnase-barstar interface. More studies are
needed to address these important issues.
A panel of TF mutants (some of them are mulï¿¾tiple point mutants) were prepared during our
TF5G9 crystal structure study. We measured the
binding constants of these mutants with 5G9 antiï¿¾body, and compared the results with the structural
Table 5. Potential hydrogen bonds between Fab 5G9 CDR and TF calculated by HBPLUS
(McDonald & Thornton, 1994)
CDR 5G9 TF Distance (AÃŠ ) Hydrogen Bond Type
L1 L30 Arg NH1 169 Lys O 3.2 Side-chainÂ±Main-chain
L2 L50 Tyr OH 171 Asn Nd
2 3.3 Side-chainÂ±Side-chain
L3 L92 Gly O 169 Lys N 3.0 Main-chainÂ±Main-chain
L94 Ser N 167 Thr O 2.9 Main-chainÂ±Main-chain
L94 Ser Og 167 Thr N 2.9 Side-chainÂ±Main-chain
H1 H30 Lys O 201 Lys Nz 2.7 Main-chainÂ±Side-chain
H31 Asp O 200 Arg NH1 3.3 Main-chainÂ±Side-chain
H33 Tyr OH 154 Thr Og 2.9 Side-chainÂ±Side-chain
H33 Tyr OH 190 Gln Oe
1 2.9 Side-chainÂ±Side-chain
H2 H52 Asp Od
1 201 Lys Nz 2.8 Side-chainÂ±Side-chain
H52 Asp Od
2 156 Tyr OH 2.9 Side-chainÂ±Side-chain
H3 H96 Asn O 200 Arg NH2 3.0 Main-chainÂ±Side-chain
H97 Ser O 169 Lys Nz 3.0 Main-chainÂ±Side-chain
H98 Tyr OH 149 Lys O 2.5 Side-chainÂ±Main-chain
H98 Tyr OH 171 Asn Nd
2 3.1 Side-chainÂ±Side-chain
884 Crystal Structures of TF, 5G9 Fab and Their Complexdata (Tables 3 and 4). Surprisingly, at Â®rst glance,
a group of TF mutants, K165A/K166A and Y157A,
have apparent inhibition constants (Ki
) that are
lower (i.e. stronger binding to Fab 5G9) than that
of wild-type TF (3.4(  0.3)  10Ã¿9 M; Ruf &
Edgington, 1994). Fab 5G9 is a competitive inhibiï¿¾tor of factor X binding to the TFVIIa complex. The
TF5G9 binding was measured indirectly through
5G9's competition with factor X for TFVIIa bindï¿¾ing (see also Materials and Methods). Since Lys165
and Lys166 of TF are critical residues for substrate
factor X association (Ruf et al., 1992a), the decrease
in Ki for these mutants is likely to result from less
efÂ®cient competition by factor X for these mutants
under the experimental conditions. The importance
of residue Tyr157, which lies underneath Lys165
and Lys166, is indirect and is likely due to its role
in positioning these lysine residues. However, we
cannot entirely exclude the possibility that the
removal of these side-chains of TF by Ala
mutations actually increases the free energy of
binding between TF and 5G9.
A strong and qualitative correlation between
structural data (number of van der Waals contacts
and contact surface area) and Ki is observed for the
mutants of key TF epitope residues (Table 4,
Figure 8). Mutation of any of these residues proï¿¾foundly diminishes the binding between TF and
5G9, and disrupts 5G9's ability to inhibit TFVIIa
complex formation. Mutation of TF Tyr156 to
alanine results in an increase of the Ki to
2.1  10Ã¿6 M, that corresponds to more than
4.0 kcal/mol reduction of binding free energy.
A double mutation of critical residues Arg200 and
Lys201 to alanine also reduces the TF5G9 binding
afÂ®nity by at least 4.0 kcal/mol. Likewise, a triple
mutation of K169A/N171A/N173A results in a
large G (Gmutant Ã¿ Gwild-type) over the wildï¿¾type (>4.0 kcal/mol). Lys169 appears to be the
most important of these three residues, as it has
the largest contact area (101 AÃŠ 2
) with Fab 5G9
among these three residues (Table 4).
A double mutation of Ser195 and Arg196 of TF
to alanine leads to a large reduction of binding
energy (>4.0 kcal/mol); there are no interactions
between these residues and Fab 5G9. It seems that
the effect of these two residues is not from direct
interactions, but rather from the local structural/
hydration rearrangements of the alanine replaceï¿¾ments. The crystal structure of TF shows that
Ser195, Arg196, Asn199, Arg200, and Lys201 are in
a loop linking b-strands F and G; the loop conforï¿¾mation appears to be stabilized by the Arg196 guaï¿¾nidinium side-chain that is deeply buried in a
pocket formed by Asn105, Phe147 and Glu199.
Mutational deletion of Arg196 may alter the conï¿¾formation of the loop, displace the key interacting
residues Arg200 and Lys201, and thus abolish the
recognition of TF by Fab 5G9. A similar argument
could be used to explain the effect of mutation on
Asn199, which has little side-chain (0.4 AÃŠ 2
) interï¿¾action with 5G9 but has a measurable effect on
5G9 binding (G of 1.1 kcal/mol) upon alanine
replacement.
Figure 8. Space-Â®lling model of the surface of the D2 module of TF. Shown in pale-blue are TF residues that are in
contact with Fab 5G9 (Table 3). Other contact residues are those that have been mutated and color-coded according
to the loss of binding free energy upon alanine substitution: red, more than 4 kcal/mol; yellow, 1 to 4 kcal/mol;
green, less than 1 kcal/mol.
Crystal Structures of TF, 5G9 Fab and Their Complex 885  TF Lys149 hydrogen-bonds to the 5G9 CDR H3
loop through its main-chain carbonyl oxygen. Fab
5G9 inhibits the double mutant K149A/D150A,
with a slightly increased Ki of 2.5(0.42)  10Ã¿8 M
(corresponding to a G of 1.2 kcal/mol).
Mutations of other C0
-strand residues of TF (T167A
and T170A mutants) have only unmeasurable or
small effects on TFVIIa inhibition (G of 0.0
and 1.0 kcal/mol, respectively), which is readily
explained by the TF5G9 structure. The TF C0
-
strand uses mostly its main-chain atoms to make
hydrogen bonds with Fab 5G9's light chain (four
out of Â®ve hydrogen bonds, Table 5), with the only
exception being the side-chain of the key Lys169
residue. These data imply that Fab 5G9's interï¿¾action with the TF C0
-strand is largely speciÂ®ed by
TF main-chain atoms.
In conclusion, our crystal structure of TF5G9
and the mutational study showed that four
(Tyr156, Lys169, Arg200, Lys201) out of 18 TF epiï¿¾tope residues have a major contribution (>4 kcal/
mol) to the 5G9 antibody recognition. Three other
residues (Lys149, Thr170, Leu176) have some effect
(1 kcal/mol) on antibody-antigen interaction.
Thus, despite our limited TF mutational study on
only a subset of the observed 5G9-interacting resiï¿¾dues, a generally good correlation between the
binding energy and the structural data, which
includes van der Waals contacts, hydrogen bondï¿¾ing, buried surface, and the charge and shape comï¿¾plementarity (Tables 3 and 4), can be seen.
However, the current crystal structure cannot comï¿¾pletely explain all of the mutational results,
especially for those mutants which have relatively
minor effects on 5G9 binding. For example, while
Leu176 of TF barely interacts with Fab 5G9 (sideï¿¾chain contact area of 2.0 AÃŠ 2
), its mutation to alaï¿¾nine causes a measurable reduction on Fab 5G9
binding (G of 1.0 kcal/mol).
Inhibitory mechanisms of Fab 5G9
The structure of the TF5G9 complex also offers
insights into 5G9's inhibition of binding of factors
IX or X to TF. As 5G9 antibody can bind to the preï¿¾formed TFVIIa complex (Ruf & Edgington, 1991),
the 5G9 antibody epitope and the VIIaTF interface
are inferred to be non-overlapping. The TFVIIa
structure (Banner et al., 1996) shows that the epiï¿¾dermal growth factor-like modules and the proï¿¾tease module of VIIa are located some distance
from the antibody epitope. The only potential overï¿¾lap would come from the VIIa Gla-module which
binds to the D2 module of TF. Positioning the Glaï¿¾module of the TFVIIa crystal structure (Banner
et al., 1996; PDB code 1dan) onto our TF5G9 strucï¿¾ture (Figure 9) by superimposing the D2-modules
of TF in the two complex structures shows close
proximity but no overlap between Fab 5G9 and the
Gla module of VIIa. Lys165 and Lys166 of TF, that
are the key residues for macromolecular substrate
factor X binding to the TFVIIa complex (Ruf et al.,
1992a), are within the TF interface with Fab 5G9.
Hence, clear overlap exists on the TF surface
between the Fab 5G9 recognition site and the proï¿¾posed binding site for factor X (Lys165 and
Lys166). Fab 5G9 then must act as a direct compeï¿¾titor for factor X substrate binding, which conÂ®rms
the previous conclusions from kinetic studies (Ruf
& Edgington, 1991).
It is noteworthy that the Gla module of VIIa also
plays an important role in the recognition of
macromolecular substrates (Ruf et al., 1991a).
Hence, both the VIIa Gla module and the adjacent
regions of TF may be the recognition surfaces for
factor X in formation of the transient ternary
TFVIIaX complex. The proximity of Fab 5G9 to
VIIa (Figure 9) implies that binding of 5G9 to TF is
also likely to hinder sterically the docking of factor
X substrate to the VIIa Gla-module, or to restrict
conformational Â¯exibility of the Gla-module and
affect factor X substrate assembly or product
release. The potent inhibitory mechanism of Fab
5G9 is, therefore, best rationalized by the occuï¿¾pancy of a surface-exposed recognition site that
plays a central role in the assembly of the
TFVIIaX transient ternary complex. A deÂ®nite
answer to this inhibitory mechanism requires a
crystal structure of the TFVIIaX ternary complex.
Materials and Methods
Crystallization and data collection (Tables 1 and 6)
Sitting-drop techniques (Stura et al., 1992) were used
in all crystallization experiments. Protein solutions
(2.5 ml) were mixed with 2.5 ml precipitant solutions; the
Figure 9. Binding of Fab 5G9 to TF does not inhibit
binding of factor VIIa. The Gla-module of VIIa in the
TFVIIa complex structure (cyan, from PDB code 1dan;
Banner et al., 1996), positioned by superimposing the TF
D2 modules of the 1dan structure to that of the TF5G9
structure, does not overlap with the epitope of Fab 5G9
(in green) in the TF D2 module which is in CPK repï¿¾resentation. Shown in gray are carbon atoms, red for
oxygen atoms, blue for nitrogen atoms and yellow for
sulfur atoms. Some selected residues of 5G9 and Glaï¿¾module are labeled to clarify the orientation.
886 Crystal Structures of TF, 5G9 Fab and Their Complex mixed solution was then allowed to equilibrate at 18C
over 1 ml of precipitant solution. X-ray diffraction data
were collected on either of two Siemens multiwire area
detectors in our laboratory using CuKa radiation from an
Elliott GX-18 rotating anode generator with a 100 mm
focal cup, operating at 40 kV and 55 mA, or a Siemens
rotation anode generator with a 300 m focal spot, operatï¿¾ing at 50 mA, 80 kV, with Franks focusing mirrors
(Harrison, 1968) and a helium cone to reduce backï¿¾ground scattering. Diffraction data were processed with
the XENGEN program package (Howard et al., 1987).
Expression and crystallization of tissue factor
The extracellular domain of human TF, consisting of
residues 1 to 218, was over-expressed in inclusion bodies
in E. coli and refolded in vitro as described (Stone et al.,
1995). TF crystals can be routinely grown from 20 mM
phosphate buffer (pH 6.5), at a 40 mg/ml protein conï¿¾centration. The Â®rst diffraction quality crystals were
actually crystallized, unexpectedly, in two days from an
NMR tube containing approximately 3.5 mM uniformly
15N-enriched (99 atom%) TF (at 85 mg/ml) in 20 mM
KNa2PO4, 0.02% (w/v) NaN3, 10% (v/v) 2
H2O and 90%
(v/v) H2O (pH 7.0) at 5C. Clusters of the shiny TF
extracellular domain crystals in the NMR tube were harï¿¾vested, separated into individual crystals, and stored in
a 10% (w/v) 10 K polyethylene glycol (PEG) solution in
a constant temperature incubator at 22C. The crystals
were stable in this solution for over a year, as judged by
their X-ray diffraction. The TF crystals have a typical size
of 0.5 mm  0.2 mm  0.3 mm, and are space group
P212121 with cell parameters of a Âˆ 64.4 AÃŠ , b Âˆ 85.8 AÃŠ ,
c Âˆ 112.9 AÃŠ . The Matthews (1968) coefÂ®cient (Vm) is
2.9 AÃŠ 3
/Dalton, assuming the asymmetric unit contains
two molecules, and corresponds to a solvent content of
55%.
Crystallization of Fab 5G9
The production, puriÂ®cation, and crystallization of
Fab 5G9 have been described (Ruf et al., 1992b). Two
slightly different crystal forms of Fab 5G9 were obtained
using 17.5% PEG 10 K at pH 8.5 and 1.35 M sodium
citrate at pH 5.5 as precipitants, and protein concenï¿¾trations of 16 mg/ml and 23 mg/ml, respectively. Both
crystal forms are orthorhombic, P212121, with typical
sizes of 0.5 mm  0.4 mm  0.3 mm (citrate form) and
0.6 mm  0.35 mm  0.2 mm (PEG form), with slightly
different cell parameters of a Âˆ 89.1 AÃŠ , b Âˆ 90.5 AÃŠ ,
c Âˆ 59.3 AÃŠ (citrate) and a Âˆ 91.6 AÃŠ , b Âˆ 93.7 AÃŠ , c Âˆ 60.7 AÃŠ
(PEG). Diffraction data from both crystal forms have
been collected to 2.4 AÃŠ . Only the crystal structure of PEG
crystal form is reported here. The PEG crystal form conï¿¾tains one Fab molecule in the asymmetric unit and has a
Matthews coefÂ®cient (Matthews, 1968) of 2.4 AÃŠ 3
/Dalton
with a solvent content of 46%.
Production, purification and crystallization of
TF5G9 complex
Crystals of Chinese hamster ovary (CHO)-expressed
TF (Ruf et al., 1992b) complexed with Fab 5G9 were
grown in 1.7 to 2.0 M ammonium sulfate, 0.1 M sodium
citrate (pH 5.0 to 5.5), 0.2% 2-methyl-2,4-pentane diol
(MPD), and 2% PEG 600 at an equal 5G9:TF molar
ratio. The crystals grew extremely slowly, taking six to
nine months to reach a maximal size of
0.4 mm  0.4 mm  0.8 mm. The crystals are monocliï¿¾nic, P2, with unit cell parameters a Âˆ 142.3 AÃŠ , b Âˆ 73.3 AÃŠ ,
c Âˆ 115.9 AÃŠ and b Âˆ 90.9. The Vm is 3.7 AÃŠ 3
/Dalton
based on two TF5G9 complex molecules in the asymï¿¾metric unit, with a solvent content of 64%.
Structure determination and
crystallographic refinement
Fab 5G9
The 5G9 structure was determined by the molecular
replacement (MR) method using X-PLOR (BruÃˆ nger,
1992b) and MERLOT (Fitzgerald, 1988) software
packages. The McPC603 (PDB code 1mcp, Satow et al.,
1986) and HyHEL-5 (PDB code 3hfm, Cohen et al., 1996;
Sheriff et al., 1987) Fabs were used as MR search models
due to their high sequence similarity to Fab 5G9. Of
these two models, HyHEL-5 has the highest amino acid
identity (82%) in both heavy and light chains, whereas
McPC603 has 80% sequence identity in the light chain,
but only 40% in the heavy chain. The McPC603, howï¿¾ever, gave the best Crowther rotation function for the
``whole'' Fab model using MERLOT. The relative orienï¿¾tation of the variable and constant domains of 5G9 was
then reÂ®ned by the PC-reÂ®nement algorithm of X-PLOR
(BruÃˆ nger et al., 1987). The X-PLOR package was also
used to solve the translation function and to reÂ®ne Fab
5G9 model using the slow cooling protocol (BruÃˆ nger
et al., 1990). Several cycles of reÂ®nement and model
building with 10% OMIT maps were carried out using
FRODO (Jones, 1978, 1982). The Fab 5G9 coordinates
have been deposited in the PDB with code 1fgn.
Tissue factor
The initial structure determination of the extracellular
domain of TF was attempted by multiple isomorphous
replacement (MIR) since no TF structure was available at
that time. The TF crystals from the NMR tube were quite
sensitive to ionic strength; the crystals crack even in
50 mM salt. A no-salt medium (10% PEG 10 K) was,
therefore, chosen as the soaking mother liquor. The pH
values of the heavy atom solutions were carefully
adjusted to the required value (pH 7) by addition of
small amounts of NaOH and HCl solutions. After an
extensive heavy atom screening of 30 possible derivaï¿¾tives, samarium chloride (SmCl3), platinum(II) 2,20
,60
,20
-
terpyridine chloride (Pt(terpy)Cl), and trimethyllead
acetate ((CH3)3PbOAc) gave reasonable isomorphism
and good quality Patterson maps (Table 6). For the
SmCl3 derivative crystal, both isomorphous and anomaï¿¾lous data were carefully collected. It is worthwhile to
note that, after soaking in the SmCl3 solution, the TF
crystals were seriously etched, lost their shiny surface
and sharp edges and became more like rugged balls. The
crystals, however, still retained a strong birefringence
and diffracted reasonably well.
The XtalView 2.0 package (McRee, 1992) was used to
merge derivative and native data and to calculate differï¿¾ence Patterson maps. Among the three derivatives,
SmCl3 had the best isomorphism. The isomorphous Patï¿¾terson map was readily solved by hand, and conÂ®rmed
by analysis of the anomalous Patterson map. Phases
from the SmCl3 derivative were used to cross-phase the
other two derivatives in order to determine their heavy
atom positions. The PHASES program package (Furey &
Swaminathan, 1990, 1997) was used to reject outliers
from the merged reÂ¯ection data, to reÂ®ne the derivatives,
Crystal Structures of TF, 5G9 Fab and Their Complex 887        and to calculate Â®nal phases. All heavy atom sites were
conÂ®rmed to be signiÂ®cant by criteria that included Â®t to
difference Patterson maps, reasonable occupancies, and
proper reÂ®nement behavior. The Â®nal Â®gure of merit
was 0.471 for 7181 phased reÂ¯ections up to 3.6 AÃŠ (see
Table 1). The relative phasing power (FH/e) of the Â®nal
MIRAS phases showed the SmCl3 derivative was stronï¿¾gest with 1.66 and 1.07 for isomorphous and anomalous
data, respectively, whereas the other two derivatives had
lower phasing powers of 0.98 (to 4.5 AÃŠ ) for the
Pb(CH3)3OAc derivative and 1.03 (to 5.5 AÃŠ ) for the
Pt(terpy)Cl derivative, which was consistent with weaker
peaks in the difference Patterson maps. These two
derivatives were included because they contributed to
the data completeness for phased reÂ¯ections in the low
resolution range, which was important for the automatic
solvent mask generation in the solvent Â¯attening proï¿¾cess.
The combined phases from these three derivatives
were then solvent Â¯attened (Wang, 1985) with the
PHASES package using a solvent content of 45%, which
is smaller than that estimated by the Matthews coefÂ®-
cient, to avoid Â¯attening the protein molecule. The elecï¿¾tron density map after solvent Â¯attening showed a clear
molecule/solvent boundary and some continuous denï¿¾sity, but the overall quality was not sufÂ®cient for an
unambiguous trace of the molecule (Figure 10). Further
solvent Â¯attening, histogram matching, and averaging
methods using DM of CCP4 (Cowtan, 1994) were
applied to the MIRAS phases using the molecular mask
and symmetry operators that relate the two TF molecules
in the asymmetric unit. The MIRAS phases were greatly
improved as judged by the drop of Rfree from 0.573 to
0.363 in the 15 to 3.6 AÃŠ range, the overall increase in the
mean Â®gure of merit (FOM) from 0.48 to 0.79, and a subï¿¾stantial improvement in the quality and interpretability
of the maps. A portion of the MIRAS map at 3.6 AÃŠ at
various stages of density modiÂ®cation is shown in
Figure 10.
Two TF crystal structures from two different laboraï¿¾tories (Harlos et al., 1994; Muller et al., 1994) were pubï¿¾lished during our heavy atom screening, and the Ca
coordinates of the 1boy TF structure became available to
us from Dr C. W. G. Boys. A backbone model of TF was
constructed using SYBYL (TRIPOS Associates Inc., 1992)
from these Ca coordinates, and the side-chains added by
the MODELLER program (Sali & Overington, 1994).
After eliminating unreasonable repulsions by hand, the
model was energy minimized to give a starting model
for molecular replacement. A rotation function solution
for one TF molecule was quite clear from both the real
space search of X-PLOR (Huber, 1985) and the reciprocal
space search by AMoRe (Navaza, 1994, implemented in
the CCP4 Suite, CCP4, 1994); the highest peak of 16.2s
intensity in the AMoRe 3.5 to 8 AÃŠ search was 4.6s above
the next peak. The correctly rotated TF model was posiï¿¾tioned into the unit cell by the phased translation funcï¿¾tion (Read & Schierbeek, 1988) using the MIRAS phases.
The phased translation function gave a strongest solution
with a peak height of 18.3s for the Â®rst TF molecule,
Table 6. Statistics for TF heavy atom derivative data
Derivative SmCl3 with anomalous Pb (CH3)3OAc Pt (terpy) Cl
Soaking conditions 1.5 mM in 10% PEG 10 K 64 mM in 10% PEG 10 K 0.6 mM in 10% PEG 10 K
at pH 7.0 for 41 hours at pH 7.0 for 4 days at pH 7.0 for 21 hours
Cell parameters (AÃŠ ) 63.6, 83.9, 111.9 63.7, 85.0, 111.7 63.5, 83.5, 111.1
No. observations 43,308 22,721 13,501
No. unique refls 22,065 7720 9885
Average I/s(I) 7.6 14.4 9.3
Completeness (%) 93.4 93.7 73.2
Resolution (AÃŠ ) 3.0 3.5 3.0
Rsyma 0.094 0.104 0.107
Rmerged 0.093 0.092 0.086
Heavy atom sites 0.616, 0.020, 0.075, 1.74 0.945, 0.093, 0.482, 1.16 0.797, 0.105, 0.626, 1.45
(x, y, z, occupancye
) 0.332, 0.206, 0.526, 0.57 0.690, 0.226, 0.005, 0.90 0.354, 0.080, Ã¿0.016, 0.26
0.791, 0.084, 0.100, 0.36
Rcullisb 0.63 0.67 0.67
Resolution (AÃŠ ) 3.6 4.5 5.5
No. refls 987 557 349
Phasing powerc 1.66 (iso) 1.07 (ano) 0.98 1.03
Figure of merit 0.471 for 7181 reflections up to 3.6 AÃŠ
a Rsym Âˆ |(h)i Ã¿ hI(h)i|/I(h)i
, with I(h)i
, observed intensity in the ith dataset and hI(h)i, mean intensity of reÂ¯ection h over all
measurements of I (h). b Rcullis Âˆ |FH(obs) Ã¿ FH(calc)|/FH(obs), in which FH(obs) is the observed heavy atom structure factor amplitude for a reÂ¯ection
and FH(calc) is the calculated amplitude. c Phasing power Âˆ hFHi/eiso, the r.m.s. heavy atom structure factor amplitude (FH) divided by the residual isomorphous lack of
closure error (eiso). d Rmerge Âˆ |FPH Ã¿ FP|/FP. e Fractional coordinates and relative occupancies. The Â®rst Sm3Â‡ ion in the samarium chloride derivative is bound to Glu128 in
both TF molecules, which is part of an electronegative patch consisting of residues Glu128, Asp129, Glu130, and Asp145.
Figure 10. Stereoview of the electron density maps around the TF disulÂ®de in module D1 at various stage of strucï¿¾ture determination. The Â®nal TF model is superimposed on the density. (a) Initial MIRAS electron density map.
(b) Solvent-Â¯attened electron density map (by PHASES, Furey & Swaminathan, 1990, 1997). (c) Solvent-Â¯attened, hisï¿¾togram-matched and averaged electron density map (by DM, Cowtan, 1994). (d) 2Fo Ã¿ Fc map derived from the Â®nal
model. All maps are contoured at 1s. This Figure was made with O (Jones et al., 1991).
888 Crystal Structures of TF, 5G9 Fab and Their ComplexFigure 10 (legend opposite)which was 13.2s higher than the next peak. The
rotational peak for the second molecule in the asymï¿¾metric unit was buried in the noise level (sixth strongest
peak in the AMoRe 3.5 to 8 AÃŠ search). The current solï¿¾ution was actually not identiÂ®ed until a later stage from
a partial T2 translational function search, which took
advantage of the Â®rst TF molecule being correctly posiï¿¾tioned. The phased translation function of this TF orienï¿¾tation gave a peak of 11.3s, which was 6.8s higher than
the next peak.
Rfree cross validation (BruÃˆ nger, 1992a), based on a 10%
randomly omitted data set, was used throughout the
reÂ®nement. The relative orientations of the TF molecules
and their D1 and D2 modules were reÂ®ned by the rigid
body reÂ®nement protocol in X-PLOR, leading to a drop
in R-value from 41.8% to 37.0% and the Rfree from 41.6%
to 37.0% for data in the 15 to 4 AÃŠ range. The next stage
of reÂ®nement and model building used 2Fo Ã¿ Fc shake
OMIT maps (McRee, 1993), generated with a random
error (0.25 AÃŠ ) added to the model. The crystal diffracï¿¾tion was found to be highly anisotropic with greater
decay along the crystallographic c* axis than along the a*
and b* axes. An overall anisotropic B-value (6.8, 4.5,
Ã¿11.3 AÃŠ 2
), estimated from X-PLOR, was applied to the
data set to correct the anisotropy. Prominent peaks in
Fo Ã¿ Fc maps and 2Fo Ã¿ Fc maps were picked and scrutiï¿¾nized against their neighboring atoms to select for
chemically reasonable water molecules. The TF coordiï¿¾nates have been deposited in the PDB with code 1tfh.
TF5G9 complex
The molecular replacement method was used to posï¿¾ition both the TF and Fab 5G9. The orientation and transï¿¾lation of 5G9 was relatively straightforward since we
had a ``perfect'' Fab model from the 5G9 structure deterï¿¾mination. The molecular replacement of TF, however,
turned out to be difÂ®cult, even though the search model
was quite close to the Â®nal model. No obvious rotation
function solutions could be identiÂ®ed by using either the
entire TF or separate D1 or D2 modules as MR models,
despite enormous searching windows (different models,
integration radii and resolution ranges) and extensive
use of many search algorithms, which included reciproï¿¾cal space search by ALMN and AMoRe (Navaza, 1994)
of CCP4, real space search (Huber, 1985) and direct
rotation search (DeLand & BruÃˆ nger, 1995) as
implemented in X-PLOR. This difÂ®culty was assumed to
stem from similarity in the topology and overall threeï¿¾dimensional structures of the TF modules and the Fab
domains (particularly with the constant domains).
Indeed, by simply subtracting the amplitudes correï¿¾sponding to the Fab component from the observed
amplitudes using the following formula (where K is the
scaling factor);
Fmodified Âˆ
ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂ
jFobsj
2 Ã¿ K  jFfabj
2
q
we were able to identify the correct rotation solution for
the D2 module of both independent TFs by X-PLOR's
rotation function and PC reÂ®nement using the modiÂ®ed
experimental amplitudes in the range of 15 to 5 AÃŠ . The
correct solution was still not the strongest peak in
X-PLOR's PC reÂ®ned list (number six on the list). Howï¿¾ever, a solution was identiÂ®ed by running the partial T2
translation function, in which the positions of Fab 5G9
were Â®xed, on the Â®rst 50 X-PLOR rotation function solï¿¾utions. The D1 module of the TF was then placed into
the cell assuming a similar intermodule angle between
D1 and D2 as that of unliganded TF; no steric clashes
resulted with neighboring molecules in the cell. The
second TF molecule of the complex was generated using
the known NCS relationship between the two 5G9 molï¿¾ecules. It is worthwhile to point out that the TF D2
search model used in this aspect of the molecular replaï¿¾cement accounts for only approximately 8% of the
scattering atoms in the asymmetric unit, which demonï¿¾strates the effectiveness of the subtraction method.
Zhang & Matthews (1994) have previously elaborated
on a similar addition/subtraction strategy to enhance
the molecular replacement method.
Before reÂ®nement, 889 reÂ¯ections (2.5% of the total
34,656 I > sI reÂ¯ections) were set aside for calculating
Rfree and monitoring the reÂ®nement process. The relative
orientation of the six domains (VH, VL, CL, CH1 of 5G9
and D1, D2 of TF) were reÂ®ned by X-PLOR's rigid body
reÂ®nement protocols in 15 to 6 AÃŠ and 15 to 4 AÃŠ resolï¿¾ution ranges; no noticeable domain movements were
observed. After the initial slow-cool reÂ®nement, the
resulting 2Fo Ã¿ Fc map was averaged by the RAVE proï¿¾gram suite (Kleywegt & Jones, 1994b), with the molecuï¿¾lar mask generated by the MAMA program (Kleywegt &
Jones, 1993). The NCS matrix was derived from the molï¿¾ecular replacement models by the lsq_explicit command
of the O program (Jones et al., 1991), and was reÂ®ned
against the 2Fo Ã¿ Fc map to give a correlation coefÂ®cient
of 0.70. The models were rebuilt according to a twofold
averaged map generated by RAVE and reÂ®ned by
X-PLOR. From this point on, only the Â®rst TF5G9 molï¿¾ecule was reÂ®ned and the second molecule was generï¿¾ated by the NCS matrix through X-PLOR's NCS strict
statement. This procedure doubled the ratio of observed
reÂ¯ections to reÂ®nement parameters to a value of 1.9.
The B-values of the model were reÂ®ned by groups (two
per residue), and were reset to 20 AÃŠ 2 before reÂ®nement.
After several cycles of positional reÂ®nement and model
building against shake OMIT maps, an R-value of 24.9%
(I > sI data) was obtained between 7.0 AÃŠ and 3.0 AÃŠ with
an Rfree of 28.1%. The model at this stage had reasonable
stereochemistry (r.m.s.d. of 0.010 AÃŠ and 2.1 for bond
lengths and bond angles, respectively), phi Âˆ psi distriï¿¾bution (73.1 residues in most favorable regions), and
real-space Â®t of the overall atoms to the 2Fo Ã¿ Fc map
(overall correlation coefÂ®cient of 0.80). The NCS conï¿¾straints were relaxed to NCS restraints with an Rfree
optimized force constant of 20 kcal/(molAÃŠ 2
) for mainï¿¾chain atoms and 10 kcal/(molAÃŠ 2
) for all other nonï¿¾hydrogen atoms; the R-value then dropped to 20.6%
(I > sI data, or 24.6% for all data). This reduction in
R-value, although accompanied by an increase in the
number of the reÂ®nement parameters due to the relaxï¿¾ation of NCS constraints, was validated by a reduction
in Rfree from 28.1% to 27.6%. The release of NCS-conï¿¾straints to NCS-restraints does not have any major effect
on the overall structure as can be seen from the relaï¿¾tively small r.m.s. deviations between NCS-restraint and
NCS-constraint models (0.23 AÃŠ each for the 196 Ca and
58 CDR Ca atoms). The TF5G9 coordinates have been
deposited in the PDB with code 1ahw.
Structure analyses
The r.m.s.d. of the CDR loops between the free and
TF-bound Fab 5G9 were calculated after superimposing
their respective framework residues of the variable
domain (light chain VL 1 to 23, 35 to 49, 57 to 88, 98 to
107, and heavy chain VH 1 to 30, 36 to 49, 67 to 98, 107
to 117) by LSQKAB (Kabsch, 1976). All residues are in
890 Crystal Structures of TF, 5G9 Fab and Their ComplexKabat-Wu numbering (Kabat et al., 1991). Ramachandran
plots were calculated by PROCHECK (Laskowski et al.,
1993), buried surface areas with the program MS
(Connolly, 1983) with a 1.7 AÃŠ probe radius (Gelin &
Karplus, 1979) and standard van der Waals radii (Case
& Karplus, 1979) with water molecules excluded from
the calculation, and hydrogen bonds and van der Waals
contacts by HBPLUS (McDonald & Thornton, 1994).
To calculate the intermodule angle of the TF structure,
the D1 and D2 modules were Â®rst superimposed by the
lsq_explicit command of O program (Jones et al., 1991)
using the following residues pairs: D1 11 Â± 17, D2 112 Â±
118; D1 21 Â± 26, D2 123 Â± 128; D1 33 Â± 39, D2 151 Â± 157; D1
46 Â± 51, D2 166 Â± 171; D1 55 Â± 59, D2 173 Â± 177; D1 70 Â± 76,
D2 186 Â± 192; D1 93 Â± 99, D2 201 Â± 207, which gives the
lowest r.m.s.d. between these two sets of Ca atoms. The
angle was then retrieved from the trace of the overlap
matrix.
Effect of TF mutations on the Ki for inhibition of
TFVIIa by Fab 5G9
Fab 5G9 is a competitive inhibitor of factor X/IX subï¿¾strate activation by the TFVIIa complex. The effects of
mutations in TF on the binding of 5G9 in a competition
assay were characterized as follows. Wild-type or
mutant TF expressed by transient transfection of Chinese
hamster ovary cells was incubated with serial dilutions
of 5G9 (0.03 to 2700 nM) for 15 minutes at ambient temï¿¾perature, followed by the addition of enzyme VIIa
(5 nM) and substrate factor X (50 nM) in the presence of
5 mM CaCl2. Factor Xa generation was quenched after
15 minutes at ambient temperature and the concenï¿¾trations of factor Xa in each reaction was quantiÂ®ed with
chromogenic p-nitroanilide substrates. Rates of factor Xa
generation versus the antibody concentration were Â®tted
to a model of competitive inhibition of the antibody with
factor X, yielding a Ki for each of the mutants and wildï¿¾type TF.
Acknowledgments
We thank Zonghao Zeng, David Jewell, Brent Segelke,
Andreas Heine, and especially Robyn L. StanÂ®eld for
advice and help. This work was supported by NIH grant
HL16411 (I.A.W., W.R., T.E.), NIH training grant Alï¿¾07354 (M.H.), and a research fellowship from the Ameriï¿¾can Heart Association, California AfÂ®liate (M.J.S.). This
is publication number 10301-MB from the Scripps
Research Institute.
References
Amit, A. G., Mariuzza, R. A., Phillips, S. E. & Poljak,
R. J. (1986). Three-dimensional structure of an antiï¿¾gen-antibody complex at 2.8 AÃŠ resolution. Science,
233, 747 Â± 753.
Arevalo, J. H., Stura, E. A., Taussig, M. J. & Wilson, I. A.
(1993). Three-dimensional structure of an anti-sterï¿¾oid Fab0 and progesterone-Fab0 complex. J. Mol.
Biol. 231, 103 Â± 118.
Ban, N., Escobar, C., Garcia, R., Hasel, K., Day, J.,
Greenwood, A. & McPherson, A. (1994). Crystal
structure of an idiotype-anti-idiotype Fab complex.
Proc. Natl Acad. Sci. USA, 91, 1604Â± 1608.
Banner, D. W., D'Arcy, A., Chene, C., Winkler, F. K.,
Guha, A., Konigsberg, W. H., Nemerson, Y. &
Kirchhofer, D. (1996). The crystal structure of the
complex of blood coagulation factor VIIa with solï¿¾uble tissue factor. Nature, 380, 41 Â± 46.
Bazan, J. F. (1990). Structural design and molecular evolï¿¾ution of a cytokine receptor superfamily. Proc. Natl
Acad. Sci. USA, 87, 6934Â± 6938.
Bernstein, F. C., Koetzle, T. F., Williams, G. J., Meyer,
E. F., Jr, Brice, M. D., Rodgers, J. R., Kennard, O.,
Shimanouchi, T. & Tasumi, M. (1978). The Protein
Data Bank: a computer-based archival Â®le for
macromolecular structures. Arch. Biochem. Biophys.
185, 584 Â± 591.
Bhat, T. N., Bentley, G. A., Boulot, G., Greene, M. I.,
Tello, D., Dall'Acqua, W., Souchon, H., Schwarz,
F. P., Mariuzza, R. A. & Poljak, R. J. (1994). Bound
water molecules and conformational stabilization
help mediate an antigen-antibody association. Proc.
Natl Acad. Sci. USA, 91, 1089Â± 1093.
Bizebard, T., Gigant, B., Rigolet, P., Rasmussen, B., Diat,
O., Bosecke, P., Wharton, S. A., Skehel, J. J. &
Knossow, M. (1995). Structure of inÂ¯uenza virus
haemagglutinin complexed with a neutralizing
antibody. Nature, 376, 92 Â± 94.
Bossart-Whitaker, P., Chang, C. Y., Novotny, J.,
Benjamin, D. C. & Sheriff, S. (1995). The crystal
structure of the antibody N10-staphylococcal nucleï¿¾ase complex at 2.9 AÃŠ resolution. J. Mol. Biol. 253,
559 Â± 575.
Braden, B. C. & Poljak, R. J. (1995). Structural features of
the reactions between antibodies and protein
antigens. FASEB J. 9, 9Â± 16.
Braden, B. C., Souchon, H., Eisele, J. L., Bentley, G. A.,
Bhat, T. N., Navaza, J. & Poljak, R. J. (1994). Threeï¿¾dimensional structures of the free and the antigenï¿¾complexed Fab from monoclonal anti-lysozyme
antibody D44.1. J. Mol. Biol. 243, 767 Â± 781.
Braden, B. C., Fields, B. A., Ysern, X., Dall'Acqua, W.,
Goldbaum, F. A., Poljak, R. J. & Mariuzza, R. A.
(1996). Crystal structure of an Fv-Fv idiotope-antiï¿¾idiotope complex at 1.9 AÃŠ resolution. J. Mol. Biol.
264, 137 Â± 151.
Brocklehurst, S. M. & Perham, R. N. (1993). Prediction
of the three-dimensional structures of the biotinyï¿¾lated domain from yeast pyruvate carboxylase and
of the lipoylated H-protein from the pea leaf glycine
cleavage system: a new automated method for the
prediction of protein tertiary structure. Protein Sci.
2, 626 Â± 639.
BruÃˆ nger, A. T. (1992a). Free R-value: a novel statistical
quantity for assessing the accuracy of crystal
structures. Nature, 355, 472 Â± 474.
BruÃˆ nger, A. T. (1992b). X-PLOR, Version 3.1: A System
for X-ray Crystallography and NMR, Yale University
Press, New Haven, CT.
BruÃˆ nger, A. T., Kuriyan, J. & Karplus, M. (1987).
Crystallographic R-factor reÂ®nement by molecular
dynamics. Science, 235, 458 Â± 460.
BruÃˆ nger, A. T., Krukowski, A. & Erickson, J. W. (1990).
Slow-cooling protocols for crystallographic reÂ®neï¿¾ment by simulated annealing. Acta Crystallog. sect.
A, 46, 585 Â± 593.
Carter, P. J., Winter, G., Wilkinson, A. J. & Fersht, A. R.
(1984). The use of double mutants to detect strucï¿¾tural changes in the active site of the tyrosyl-tRNA
synthetase (Bacillus stearothermophilus). Cell, 38, 835 Â±
840.
Crystal Structures of TF, 5G9 Fab and Their Complex 891Case, D. A. & Karplus, M. (1979). Dynamics of ligand
binding to heme proteins. J. Mol. Biol. 132, 343Â±368.
CCP4 (1994). The CCP4 suite: programs for protein
crystallography. Acta Crystallog. sect. D, 50, 760Â±
763.
Chacko, S., Silverton, E. W., Kam-Morgan, L., Smithï¿¾Gill, S. J., Cohen, G. H. & Davies, D. R. (1995).
Structure of an antibody-lysozyme complex: unexï¿¾pected effect of a conservative mutation. J. Mol.
Biol. 245, 261Â±274.
Chitarra, V., Alzari, O. M., Bentley, G. A., Bhat, T. N.,
Eisele, J. L., Houdusse, A., Lescar, J., Souchon, H. &
Poljak, R. J. (1993). Three-dimensional structure of a
heteroclitic antigen-antibody cross-reaction complex.
Proc. Natl Acad. Sci. USA, 90, 7711Â±7715.
Chothia, C., Lesk, A. M., Tramontano, A., Levitt, M.,
Smith-Gill, S. J., Air, G., Sheriff, S., Padlan, E. A.,
Davies, D., Tulip, W. R., Colman, P. M., Spinelli, S.,
Alzari, P. M. & Poljak, R. J. (1989). Conformations
of immunoglobulin hypervariable regions. Nature,
342, 877Â±883.
Clackson, T. & Wells, J. A. (1995). A hot spot of binding
energy in a hormone-receptor interface. Science, 267,
383Â±386.
Cohen, G. H., Sheriff, S. & Davies, D. R. (1996). ReÂ®ned
structure of the monoclonal antibody HyHEL-5
with its antigen hen egg-white lyzozyme. Acta Crysï¿¾tallog. sect. D, 52, 315Â±326.
Connolly, M. L. (1983). Solvent-accessible surfaces of
proteins and nucleic acids. Science, 221, 709Â±713.
Covell, D. G. & Wallqvist, A. (1997). Analysis of proï¿¾tein-protein interactions and the effects of amino
acid mutations on their energetics: the importance
of water molecules in the binding epitope. J. Mol.
Biol. 269, 281Â±297.
Cowtan, K. (1994). Joint CCP4 and ESF-EACBM Newsletï¿¾ter on Protein Crystallography, 31, 34Â±38.
Davies, D. R. & Cohen, G. H. (1996). Interactions of proï¿¾tein antigens with antibodies. Proc. Natl Acad. Sci.
USA, 93, 7Â±12.
Davies, D. R., Padlan, E. A. & Sheriff, S. (1990).
Antibody-antigen complexes. Annu. Rev. Biochem.
59, 439Â±473.
DeLand, A. L. & BruÃˆ nger, A. T. (1995). The direct
rotation function: rotational Patterson correlation
search applied to molecular replacement. Acta Crysï¿¾tallog. sect. D, 51, 740Â±748.
Dickinson, C. D., Kelly, C. R. & Ruf, W. (1996).
IdentiÂ®cation of surface residues mediating tissue
factor binding and catalytic function of the serine
protease factor VIIa. Proc. Natl Acad. Sci. USA, 93,
14379Â±14384.
Edgington, T. S., Mackman, N., Fan, S. T. & Ruf, W.
(1992). Cellular immune and cytokine pathways
resulting in tissue factor expression and relevance
to septic shock. Nouv. Rev. Fr. Hematol. 34(Suppl.),
S15Â±S27.
Ferrin, T. E., Huang, C. C., Jarvis, L. E. & Langridge, R.
(1988). The Midas display system. J. Mol. Graph. 6,
13Â±27.
Fersht, A. R., Shi, J.-P., Knill-Jones, J., Lowe, D. M.,
Wilkinson, A. T., Blow, D. M., Brick, P., Carter, P.,
Ware, M. M. Y. & Winter, G. (1985). Hydrogen
bonding and biological speciÂ®city analysed by proï¿¾tein engineering. Nature, 314, 235Â±238.
Fields, B. A., Goldbaum, F. A., Ysern, X., Poljak, R. J. &
Mariuzza, R. A. (1995). Molecular basis of antigen
mimicry by an anti-idiotope. Nature, 374, 739Â±742.
Fischmann, T. O., Bentley, G. A., Bhat, T. N., Boulot, G.,
Mariuzza, R. A., Phillips, S. E., Tello, D. & Poljak,
R. J. (1991). Crystallographic reÂ®nement of the
three-dimensional structure of the Fab D1.3 lysoï¿¾zyme complex at 2.5 AÃŠ resolution. J. Biol. Chem. 266,
12915Â±12920.
Fitzgerald, P. M. D. (1988). MERLOT, an integrated
package of computer programs for the determiï¿¾nation of crystal structures by molecular
replacement. J. Appl. Crystallog. 21, 273Â±278.
Furey, W. & Swaminathan, S. (1990). ``PHASES'' - a proï¿¾gram package for the processing and analysis of
diffraction data from macromolecules. PA33, Am.
Crystallog. Assoc. Abstr. ser. 2, 18, 73.
Furey, W. & Swaminathan, S. (1997). PHASES-95: a proï¿¾gram package for the processing and analysis of
diffraction data from macromolecules. In Methods in
Enzymology: Macromolecular Crystallography, Part B
(Carter, C. & Sweet, R., eds), p. 277, Academic
Press, Orlando, FL.
Gelin, B. R. & Karplus, M. (1979). Side-chain torsional
potentials: effect of dipeptide, protein, and solvent
environment. Biochemistry, 18, 1256Â±1268.
Harlos, K., Martin, D. M., O'Brien, D. P., Jones, E. Y.,
Stuart, D. I., Polikarpov, I., Miller, A., Tuddenham,
E. G. & Boys, C. W. G. (1994). Crystal structure of
the extracellular region of human tissue factor.
Nature, 370, 662Â±666.
Harrison, S. C. (1968). A point-focusing camera for
single-crystal diffraction. J. Appl. Crystallog. 1, 84Â±
90.
Herron, J. N., He, X. M., Ballard, D. W., Blier, P. R.,
Pace, P. E., Bothwell, A. L., Voss, E. W., Jr &
Edmundson, A. B. (1991). An autoantibody to
single-stranded DNA: comparison of the threeï¿¾dimensional structures of the unliganded Fab and a
deoxynucleotide-Fab complex. Proteins: Struct.
Funct. Genet. 11, 159Â±175.
Herzberg, O., Chen, C. C., Kapadia, G., McGuire, M.,
Carroll, L. J., Noh, S. J. & Dunaway-Mariano, D.
(1996). Swiveling-domain mechanism for enzymatic
phosphotransfer between remote reaction sites.
Proc. Natl Acad. Sci. USA, 93, 2653Â±2657.
Horovitz, A. (1996). Double-mutant cycles: a powerful
tool for analyzing protein structure and function.
Fold. Design, 1, R121Â±R126.
Howard, A. J., Gilliland, G. L., Finzel, B. C., Poulus,
T. L., Ohlendorf, D. H. & Salemme, F. R. (1987).
The use of an imaging proportional counter in
macromolecular crystallography. J. Appl. Crystallog.
20, 383Â±387.
Huang, C. C., Pettersen, E. F., Klein, T. E. & Langridge,
R. (1991). CONIC: a fast renderer for space-Â®lling
molecules with shadows. J. Mol. Graph. 9, 230Â±236.
Huber, R. (1985). In Proceedings of the Daresbury Study
Weekend, pp. 58Â±61, Daresbury Laboratory, Daresï¿¾bury, Warrington WA4 4AD, UK.
Jones, S. & Thornton, J. M. (1996). Principles of proteinï¿¾protein interactions. Proc. Natl Acad. Sci. USA, 93,
13Â±20.
Jones, T. A. (1978). A graphics model building and
reÂ®nement system for macromolecules. J. Appl.
Crystallog. 11, 268Â±272.
Jones, T. A. (1982). FRODO: a graphics Â®tting program
for macromolecules. In Computational Chemistry
(Sayre, D., ed.), pp. 303Â±317, Clarendon Press,
Oxford.
Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M.
(1991). Improved methods for building protein
892 Crystal Structures of TF, 5G9 Fab and Their Complexmodels in electron density maps and the locations
of errors in three models. Acta Crystallog. sect. A, 47,
110Â±119.
Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S. &
Foeller, C. (1991). Sequences of Proteins of Immunoï¿¾logical Interest, 5th edit., National Institutes of
Health, Bethesda.
Kabsch, W. (1976). A solution for the best rotation to
relate two sets of vectors. Acta Crystallog. sect. A, 32,
922Â±923.
Kelley, R. F., Costas, K. E., O'Connell, M. P. & Lazarus,
R. A. (1995). Analysis of the factor VIIa binding site
on human tissue factor: effects of tissue factor
mutations on the kinetics and thermodynamics of
binding. Biochemistry, 34, 10383Â±10392.
Kleywegt, G. J. & Jones, T. A. (1993). Masks made easy.
In ESF/CCP4 Newsletter, pp. 56Â±59.
Kleywegt, G. J. & Jones, T. A. (1994a). A super position.
In ESF/CCP4 Newsletter, pp. 9Â±14.
Kleywegt, G. J. & Jones, T. A. (1994b). Halloween ...
masks and bones. In From First Map to Final Model,
Proceedings of the CCP4 Study Weekend (Bailey, S.,
Hubbard, R. & Waller, D., eds), pp. 59Â±66,
Daresbury, UK.
Krishnaswamy, S., Field, K. A., Edgington, T. S.,
Morrissey, J. H. & Mann, K. G. (1992). Role of the
membrane surface in the activation of human
coagulation factor X. J. Biol. Chem. 267, 26110Â±
26120.
Laskowski, R. A., MacArthur, M. W., Mass, D. S. &
Thornton, J. M. (1993). PROCHECK: a program to
check the stereochemical quality of protein
structures. J. Appl. Crystallog. 26, 283Â±291.
Lescar, J., Souchon, H. & Alzari, P. M. (1994). Crystal
structures of pheasant and guinea fowl egg-white
lysozymes. Protein Sci. 3, 788Â±798.
Levi, M., tenCate, H., Bauer, K. A., van der Poll, T.,
Edgington, T. S., Buller, H. R., van Deventer, S. J.,
Hack, C. E., tenCate, J. W. & Rosenberg, R. D.
(1994). Inhibition of endotoxin-induced activation of
coagulation and Â®brinolysis by pentoxifylline or by
a monoclonal anti-tissue factor antibody in
chimpanzees. J. Clin. Invest. 93, 114Â±120.
Luzzati, V. (1952). Traitement statistique des erreurs
dans la determination des structures cristallines.
Acta Crystallog. 5, 802Â±810.
Malby, R. L., Tulip, W. R., Harley, V. R., McKimmï¿¾Breschkin, J. L., Laver, W. G., Webster, R. G. &
Colman, P. M. (1994). The structure of a complex
between the NC10 antibody and inÂ¯uenza virus
neuraminidase and comparison with the overlapï¿¾ping binding site of the NC41 antibody. Structure,
2, 733Â±746.
Martin, D. M., Boys, C. W. G. & Ruf, W. (1995). Tissue
factor: molecular recognition and cofactor function.
FASEB J. 9, 852Â±859.
Matthews, B. W. (1968). Solvent content of protein
crystals. J. Mol. Biol. 33, 491Â±497.
McDonald, I. K. & Thornton, J. M. (1994). Satisfying
hydrogen bonding potential in proteins. J. Mol. Biol.
238, 777Â±793.
McRee, D. E. (1992). A visual protein crystallographic
software system for X11/Xview. J. Mol. Graph. 10,
44Â±47.
McRee, D. E. (1993). Practical Protein Crystallography,
Academic Press Inc., San Diego.
Miller, S., Janin, J., Lesk, A. M. & Chothia, C. (1987).
Interior and surface of monomeric proteins. J. Mol.
Biol. 196, 641Â±656.
Milner-White, E. J., Ross, B. M., Ismail, R., Belhadjï¿¾Mostefa, K. & Poet, R. (1988). One type of gammaï¿¾turn, rather than the other gives rise to chain-reverï¿¾sal in proteins. J. Mol. Biol. 204, 777Â±782.
Muller, Y. A., Ultsch, M. H., Kelley, R. F. & de Vos,
A. M. (1994). Structure of the extracellular domain
of human tissue factor: location of the factor VIIa
binding site. Biochemistry, 33, 10864Â±10870.
Muller, Y. A., Ultsch, M. H. & de Vos, A. M. (1996). The
crystal structure of the extracellular domain of
human tissue factor reÂ®ned to 1.7 AÃŠ resolution.
J. Mol. Biol. 256, 144Â±159.
Navaza, J. (1994). AMoRe: an automated package for
molecular replacement. Acta Crystallog. sect. A, 50,
157Â±163.
Nicholls, A., Sharp, K. A. & Honig, B. (1991). Protein
folding and association: insights from the interfacial
and thermodynamic properties of hydrocarbons.
Proteins: Struct. Funct. Genet. 11, 281Â±296.
Novotny, J., Bruccoleri, R. E. & Saul, F. A. (1989). On
the attribution of binding energy in antibody-antiï¿¾gen complexes McPC603, D1.3 and HyHEL-5. Bioï¿¾chemistry, 28, 4735Â±4749.
Nuss, J. M., Whitaker, P. B. & Air, G. M. (1993).
IdentiÂ®cation of critical contact residues in the
NC41 epitope of a subtype N9 inÂ¯uenza virus
neuraminidase. Proteins: Struct. Funct. Genet. 15,
121Â±132.
Padlan, E. A. (1994). Anatomy of the antibody molecule.
Mol. Immun. 31, 169Â±217.
Padlan, E. A., Silverton, E. W., Sheriff, S., Cohen, G. H.,
Smith-Gill, S. J. & Davies, D. R. (1989). Structure of
an antibody-antigen complex: crystal structure of
the HyHEL-10 Fab-lysozyme complex. Proc. Natl
Acad. Sci. USA, 86, 5938Â±5942.
Prasad, L., Sharma, S., Vandonselaar, M., Quail, J. W.,
Lee, J. S., Waygood, E. B., Wilson, K. S., Dauter,
Z. & Delbaere, L. T. (1993). Evaluation of mutagenï¿¾esis for epitope mapping: structure of an antibodyï¿¾protein antigen complex. J. Biol. Chem. 268, 10705Â±
10708.
Read, R. J. & Schierbeek, A. J. (1988). A phased transï¿¾lation function. J. Appl. Crystallog. 21, 490Â±495.
Rini, J. M., Schulze-Gahmen, U. & Wilson, I. A. (1992).
Structural evidence for induced Â®t as a mechanism
for antibody-antigen recognition. Science, 255, 959Â±
965.
Ruf, W. & Edgington, T. S. (1991). An anti-tissue factor
monoclonal antibody which inhibits TF:VIIa comï¿¾plex is a potent anticoagulant in plasma. Thromb.
Haemost. 66, 529Â±533.
Ruf, W. & Edgington, T. S. (1994). Structural biology of
tissue factor, the initiator of thrombogenesis in vivo.
FASEB J. 8, 385Â±390.
Ruf, W., Kalnik, M. W., Lund-Hansen, T. & Edgington,
T. S. (1991a). Characterization of factor VII associï¿¾ation with tissue factor in solution: high and low
afÂ®nity calcium binding sites in factor VII contribï¿¾ute to functionally distinct interactions. J. Biol.
Chem. 266, 15719Â±15725.
Ruf, W., Rehemtulla, A. & Edgington, T. S. (1991b).
Antibody mapping of tissue factor implicates two
different exon-encoded regions in function. Biochem.
J. 278, 729Â±733.
Ruf, W., Rehemtulla, A., Morrissey, J. H. & Edgington,
T. S. (1991c). Phospholipid-independent and -depenï¿¾dent interactions required for tissue factor receptor
and cofactor function. J. Biol. Chem. 266, 2158Â±2166.
Crystal Structures of TF, 5G9 Fab and Their Complex 893Ruf, W., Miles, D. J., Rehemtulla, A. & Edgington, T. S.
(1992a). Co-factor residues lysine 165 and 166 are
critical for protein substrate recognition by the tisï¿¾sue factor-factor VIIa protease complex. J. Biol.
Chem. 267, 6375Â± 6381.
Ruf, W., Stura, E. A., LaPolla, R. J., Syed, R., Edgington,
T. S. & Wilson, I. A. (1992b). PuriÂ®cation, sequence
and crystallization of an anti-tissue factor Fab and
its use for the crystallization of tissue factor.
J. Crystal Growth, 122, 253 Â± 264.
Ruf, W., Schullek, J. R., Stone, M. J. & Edgington, T. S.
(1994). Mutational mapping of functional residues
in tissue factor: identiÂ®cation of factor VII recogï¿¾nition determinants in both structural modules of
the predicted cytokine receptor homology domain.
Biochemistry, 33, 1565Â± 1572.
Sali, A. & Overington, J. P. (1994). Derivation of rules
for comparative protein modeling from a database
of protein structure alignments. Protein Sci. 3, 1582Â±
1596.
Satow, Y., Cohen, G. H., Padlan, E. A. & Davies, D. R.
(1986). Phosphocholine binding immunoglobulin
Fab McPC603: an X-ray diffraction study at 2.7 AÃŠ .
J. Mol. Biol. 190, 593 Â±604.
Schreiber, G. & Fersht, A. R. (1993). The interaction of
barnase with its polypeptide inhibitor barstar stuï¿¾died by protein engineering. Biochemistry, 32, 5145Â±
5150.
Schreiber, G. & Fersht, A. R. (1995). Energetics of proï¿¾tein-protein interactions: analysis of the barnase-barï¿¾star interface by single mutations and double
mutant cycles. J. Mol. Biol. 248, 478 Â± 486.
Sheriff, S. (1993). Antibody-protein complexes. Immunoï¿¾methods, 3, 222 Â± 227.
Sheriff, S. (1997). Antibody-antigen complexes, crystalloï¿¾graphic structures. In Encyclopedia of Immunology
(Delves, P., ed.), 2nd edit., Academic Press, London.
Sheriff, S., Silverton, E. W., Padlan, E. A., Cohen, G. H.,
Smith-Gill, S. J., Finzel, B. C. & Davies, D. R. (1987).
Three-dimensional structure of an antibody-antigen
complex. Proc. Natl Acad. Sci. USA, 84, 8075Â± 8079.
StanÂ®eld, R. L., Fieser, T. M., Lerner, R. A. & Wilson,
I. A. (1990). Crystal structures of an antibody to a
peptide and its complex with peptide antigen at
2.8 AÃŠ . Science, 248, 712 Â± 719.
StanÂ®eld, R. L., Takimoto-Kamimura, M., Rini, J. M.,
Profy, A. T. & Wilson, I. A. (1993). Major antigenï¿¾induced domain rearrangements in an antibody.
Structure, 1, 83 Â± 93.
Stone, M. J., Ruf, W., Miles, D. J., Edgington, T. S. &
Wright, P. E. (1995). Recombinant soluble human
tissue factor secreted by Saccharomyces cerevisiae and
refolded from Escherichia coli inclusion bodies: glyï¿¾cosylation of mutants, activity and physical
characterization. Biochem. J. 310, 605 Â± 614.
Stura, E. A., Chen, P., Arevalo, J. H. & Wilson, I. A.
(1992). Crystallization studies of glycosylated and
unglycosylated human recombinant interleukin-2.
Proteins: Struct. Funct. Genet. 12, 24 Â± 30.
TRIPOS Associates Inc. (1992). SYBYL: molecular model
software, 6th edit., St. Louis, Missouri.
Tulip, W. R., Varghese, J. N., Laver, W. G., Webster,
R. G. & Colman, P. M. (1992a). ReÂ®ned crystal
structure of the inÂ¯uenza virus N9 neuraminidaseï¿¾NC41 Fab complex. J. Mol. Biol. 227, 122 Â± 148.
Tulip, W. R., Varghese, J. N., Webster, R. G., Laver,
W. G. & Colman, P. M. (1992b). Crystal structures
of two mutant neuraminidase-antibody complexes
with amino acid substitutions in the interface. J. Mol.
Biol. 227, 149 Â± 159.
Wallqvist, A. & Covell, D. G. (1996). Docking enzymeï¿¾inhibitor complexes using a preference based freeï¿¾energy surface. Proteins: Struct. Funct. Genet. 25,
403 Â± 419.
Wang, B. C. (1985). Resolution of phase ambiguity in
macromolecular crystallography. Methods Enzymol.
115, 90 Â± 112.
Webster, D. M., Henry, A. H. & Rees, A. R. (1994).
Antibody-antigen interactions. Curr. Opin. Struct.
Biol. 4, 123 Â±129.
Wells, J. A. (1996). Binding in the growth hormone recepï¿¾tor complex. Proc. Natl Acad. Sci. USA, 93, 1 Â± 6.
Wilson, I. A. & StanÂ®eld, R. L. (1993). Antibody-antigen
interactions. Curr. Opin. Struct. Biol. 3, 113 Â± 118.
Wilson, I. A. & StanÂ®eld, R. L. (1994). Antibody-antigen
interactions: new structures and new conformationï¿¾al changes. Curr. Opin. Struct. Biol. 4, 857 Â± 867.
Wilson, I. A., Rini, J. M., Fremont, D. H., Fieser, G. G. &
Stura, E. A. (1991a). X-ray crystallographic analysis
of free and antigen-complexed Fab fragments to
investigate structural basis of immune recognition.
Methods Enzymol. 203, 153 Â±176.
Wilson, I. A., StanÂ®eld, R. L., Rini, J. M., Arevalo, J. H.,
Schulze-Gahmen, U., Fremont, D. H. & Stura, E. A.
(1991b). Structural aspects of antibodies and antiï¿¾body-antigen complexes. Ciba Found. Symp. 159,
13 Â±28.
Wukovitz, S. W. & Yeates, T. O. (1995). Why protein
crystals favour some space-groups over others.
Nature Struct. Biol. 2, 1062Â± 1067.
Zhang, X.-J. & Matthews, B. W. (1994). Enhancement of
the method of molecular replacement by incorporï¿¾ation of known structural information. Acta Crystalï¿¾log. sect. D, 50, 675 Â± 686.
Edited by D. C. Rees
(Received 30 May 1997; received in revised form
23 October 1997; accepted 24 October 1997)
http://www.hbuk.co.uk/jmb
Supplementary material for this paper, comprising
two Figures (three parts for each Figure) is availï¿¾able from JMB Online.
894 Crystal Structures of TF, 5G9 Fab and Their Complex